bromocriptine has been researched along with Hyperprolactinemia in 451 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 156 (34.59) | 18.7374 |
| 1990's | 172 (38.14) | 18.2507 |
| 2000's | 69 (15.30) | 29.6817 |
| 2010's | 46 (10.20) | 24.3611 |
| 2020's | 8 (1.77) | 2.80 |
| Authors | Studies |
|---|---|
| Clausen, MF; Fosbøl, E; Gislason, G; Kristensen, SL; Køber, L; Rørth, R; Torp-Pedersen, C; Weeke, PE; Westergaard, LM | 1 |
| Ding, Y; Feng, H; Jiang, X; Zhong, Q; Zhou, H | 1 |
| Akhtar, MF; Akter, R; Al-Harrasi, A; Berrada, M; Bhatia, S; Damiri, F; Ferdous Mitu, J; Kabir, MT; Rahman, MH; Rahman, MS; Saleem, A | 1 |
| Abbas, M; Mahmood, Q; Mahmood, Z; Malik, A; Mehmood, MH; Naz, F; Rasool, G; Riaz, M | 1 |
| Hamidianjahromi, A; Tritos, NA | 1 |
| Auriemma, RS; Colao, A; Graziadio, C; Pirchio, R; Pivonello, R | 1 |
| Huang, Q; Li, M; Tan, J; Zeng, Y; Zhou, W; Zou, Y | 1 |
| Cescato, VAS; Cunha-Neto, MBC; Glezer, A; Musolino, NRC; Pinheiro, FMM; Silva, GO; Stumpf, MAM | 1 |
| Araujo, B; Belo, S; Carvalho, D | 1 |
| Li, J; McGregor, HP | 1 |
| Bilbao, I; Egaña, N; García, C; Olaizola, I | 1 |
| Ach, K; Beizig, AM; Chadli, MC; El Abed, YH; Maha, KN; Taieb, A | 1 |
| Krysiak, R; Okopień, B; Szkróbka, W | 2 |
| Michael Besser, G; Pfeiffer, RF; Thorner, MO | 1 |
| Almeida, R; Araújo, C; Marques, O; Santos, MJ | 1 |
| Huang, HY; Hui, GZ; Tang, H; Wu, ZB; Zhai, W | 1 |
| Shoenfeld, Y; Vieira Borba, V | 1 |
| Lajud, N; Olvera-Cortés, E; Quintanar-Stéphano, A; Tinajero, E; Torner, L | 1 |
| Deng, YS; Gan, QS; Li, XY; Su, FY; Wu, XN; Wu, YF; Zhou, JF | 1 |
| Carvalheiro, M; Gomes, L; Paiva, S; Ruas, L; Saraiva, J | 1 |
| Angsuwatthana, S; Dangrat, C; Rattanachaiyanont, M; Saejong, R; Tanmahasamut, P; Techatrisak, K | 1 |
| Aquino, NS; Araujo-Lopes, R; Crampton, JR; Franci, CR; Grattan, DR; Kokay, IC; Miranda, RM; Reis, AM; Szawka, RE | 1 |
| Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G | 1 |
| Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R | 1 |
| Bretón Lesmes, I; Cózar León, MV; García de Quirós Muñoz, JM; Serrano Aguayo, P | 1 |
| Krysiak, R; Okopien, B | 1 |
| Krysiak, R; Okopien, B; Okrzesik, J | 1 |
| Akbaba, G; Arduc, A; Aydin, Y; Berker, D; Gokay, F; Guler, S; Isik, S; Kucukler, FK; Ozuguz, U; Tutuncu, Y | 1 |
| Finny, P; Jacob, R; Seshadri, MS; Stephen, C; Tharyan, P | 1 |
| Dongying, C; Fan, L; Hanshi, X; Hao, L; Liuqin, L; Qian, Q; Shiwen, Y; Xiuyan, Y; Yujin, Y; Zhongping, Z | 1 |
| Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
| Couldwell, WT; Eloy, JA; Liu, JK; Wong, A | 1 |
| Hou, L; Qin, F; Wang, C; Wang, L; Wang, X; Wei, Y; Yu, Z; Zhou, W | 1 |
| Couldwell, WT; Eloy, JA; Hajart, AF; Jethwa, PR; Liu, JK; Patel, TD | 1 |
| Al-Tajali, A; Naguy, A | 1 |
| Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y | 1 |
| Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S | 1 |
| Chen, H; Fu, J; Huang, W | 1 |
| Braga, J; Galvão, A; Gonçalves, D; Inocêncio, G; Moreira, M; Silva, C | 1 |
| Espinoza, LR; Jara, LJ; Medina, G; Navarro, C; Saavedra, MA; Torres-Aguilar, H; Vazquez Del Mercado, M; Vera-Lastra, O | 1 |
| Azevedo, M; Barros, AI; Bronstein, MD; Casulari, LA; Cruz, TP; Czepielewski, MA; Faria, M; Freitas, MC; Gadelha, MR; Glezer, A; Lamounier Filho, A; Lima, JG; Montenegro, R; Mota, A; Nascimento, GC; Naves, LA; Nóbrega, LH; Ramos, A; Vilar, L; Violante, A | 1 |
| Chen, ZJ; Gao, Q; Liu, H; Ma, ZX; Sheng, Y; Shi, YH; Yan, JH | 1 |
| Eftekhari, N; Mohammadalizadeh, S | 1 |
| Martin, NM; Meeran, K; Tan, T | 1 |
| Aviello, G; Borrelli, F; Capasso, F; Capasso, R; Izzo, AA; Lembo, F; Savino, F | 1 |
| Pullan, PT | 1 |
| An, H; Joe, SH; Jung, IK; Ko, YH; Lee, MS; Song, HC; Yang, J | 1 |
| Ben Hadj, AB; Ben Nasr, S; Ghanem, A; Mouna, A | 1 |
| Kostic, G; Markovic, I; Miljkovic, P; Radovanovic, Z; Saranac, L; Zivanovic, S | 1 |
| Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K | 1 |
| Bahceci, M; Sismanoglu, A; Ulug, U | 1 |
| Babakhani, L; Fereshtehnejad, SM; Mojthahedi, K; Motazedian, S | 1 |
| Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG | 1 |
| Lee, J; Ng, KW; Swapna, V | 1 |
| Boguszewski, CL; dos Santos Nunes, V; El Dib, R; Nogueira, CR | 1 |
| Molitch, ME | 4 |
| Feng, YB; McAlonan, GM; Sze, SC; Wang, D; Wang, XM; Wong, HK; Zhang, L; Zhang, ZJ | 1 |
| Ahtiainen, P; Calandra, RS; Di Giorgio, NP; Gonzalez, B; Huhtaniemi, IT; Poutanen, M; Ratner, LD; Rulli, SB | 1 |
| Bian, J; Deng, CH; Huang, YP; Liu, CD; Sun, XZ; Ye, YL | 1 |
| Abaci, A; Altincik, A; Bober, E; Buyukgebiz, A; Can, S; Catli, G; Demir, K | 1 |
| Bazer, FW; Carpenter, KD; Gertler, A; Gray, CA; Noel, S; Spencer, TE | 1 |
| Mah, PM; Webster, J | 1 |
| Cavallero, D; Fazzuoli, L; Giusti, M; Valenti, S | 1 |
| Agarwal, N; Suneja, A | 1 |
| Bankowski, BJ; Zacur, HA | 1 |
| Akalin, S; Akpinar, I; Deyneli, O; Gözü, H; Haklar, G; Sezgin, O; Yavuz, D; Yildiz, E | 1 |
| Aslan, E; Bagis, T; Erkanli, S; Kilicdag, EB; Kuscu, E; Ozsahin, K; Tarim, E | 1 |
| Murai, T; Murakami, N; Nagai, T; Obata, K; Sakazume, S; Sakuta, R; Takahashi, E; Yoshino, A | 1 |
| Diamond, B; Michael, D; Peeva, E; Venkatesh, J | 1 |
| Bliesener, N; Klingmüller, D; Kühn, KU; Quednow, BB; Yokusoglu, H | 1 |
| Baran, AS; Rack, MJ; Richert, AC; Roffwarg, HP | 1 |
| Miller, DE; Sebastian, CS | 1 |
| Darwish, AM; El-Gebali, I; Hafez, E; Hassan, SB | 1 |
| Abs, R; Verhelst, J | 1 |
| Herman, ZS; Krysiak, R; Okopieh, B | 1 |
| Saie, DJ; Sills, ES | 1 |
| Crosignani, PG | 1 |
| Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML | 1 |
| Barlier, A; Jaquet, P | 1 |
| Bellini, MJ; Carino, MH; Goya, RG; Tacconi-Gómez Dumm, N | 1 |
| Faridi, MM; Shah, D; Verma, S | 1 |
| Iura, T; Makinoda, S; Neyatani, N | 1 |
| Sugino, N | 1 |
| Colao, A; De Leo, M; Di Sarno, A; Guerra, E; Lombardi, G; Mentone, A | 1 |
| Pakawut, N; Panamonta, O | 1 |
| Mascarell, S; Sarne, DH | 1 |
| Tokhunts, KA | 1 |
| Chuang, E; Molitch, ME | 1 |
| Darwish, AM; Farah, E; Gadallah, WA; Mohammad, II | 1 |
| Konopelska, S; Quinkler, M; Strasburger, CJ; Ventz, M | 1 |
| Casanueva, FF; Giustina, A; Mancini, T | 1 |
| Caldas, D; Cesar de Oliveira Naliato, E; Colao, A; Dutra Violante, AH; Fontes, R; Gomes de Souza, R; Guerra, E; Lamounier Filho, A; Rezende Loureiro, C; Schrank, Y; Sebastian, A; Vaisman, M | 1 |
| Darwish, AM; El-Harras, SA; El-Sayed, AM; Ismail, MA; Khaled, KA | 1 |
| Feng, XJ; Liu, RM; Sze, CW; Tan, QR; Tong, Y; Wang, CY; Yuan, HN; Zhang, JZ; Zhang, YB; Zhang, ZJ | 1 |
| Alves, SB; Bonomo, IT; de Moura, EG; Lisboa, PC; Passos, MC; Reis, AM | 1 |
| Fingerová, H; Gazárek, F; Stehlíková, J; Talas, M; Zenísek, L | 1 |
| Kobilková, J; Kucera, E; Marek, J; Srámková, J; Zivný, J | 1 |
| Alexander, H; Herter, U; Ulrich, FE | 1 |
| Bartke, A; Doherty, PC; Karasek, M | 1 |
| Dardenne, M; Kelly, PA; Kuttenn, F; Leite-de-Moraes, MC; Touraine, P | 1 |
| Abs, R; Beckers, A; Verhelst, J | 1 |
| Janejindamai, S; Jaruratanasirikul, S | 1 |
| Bryson, HM; Fitton, A; Rains, CP | 1 |
| Allen, SH; Hoffman, RW; McMurray, RW; Walker, SE | 1 |
| Rüedi, B | 1 |
| Cohen, AJ | 1 |
| Bosc, M; Leclere, J; Pascal-Vigneron, V; Weryha, G | 1 |
| Jacobs, HS; Soule, SG | 1 |
| Hardy, KJ; Seckl, JR | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Landi, ML; Merola, B; Nappi, C; Sarnacchiaro, F; Schettini, G; Selleri, A | 1 |
| Aisaka, K; Kayama, F; Kimura, Y; Matsuoka, R; Mori, H; Satoh, K; Tamechika, S; Yoshida, K | 1 |
| Govardhani, M; Krishna, PT; Prathibha, D | 1 |
| Burke, CW; Vilar, L | 1 |
| Duthel, R; Estour, B; Malluret, J; Rachidi-Koussa, H; Vergely, N | 1 |
| Beardwell, CG; O'Halloran, DJ; Razzaq, R; Shalet, SM | 1 |
| Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M | 1 |
| Fraser, RB; Jones, TH | 1 |
| Garcia, MB; Koppeschaar, HP; Krenning, EP; Lips, CJ; Thijssen, JH | 1 |
| Ferrari, CI; Ismail, I; Piscitelli, G; Polli, A; Scanlon, MF; Webster, J | 1 |
| Serri, O | 1 |
| Furudate, S; Hokao, R; Saito, TR; Takahashi, KW; Tohei, A | 1 |
| Ajmani, AK; Dash, RJ; Sialy, R | 1 |
| Vaidya, RA | 1 |
| Chandy, MJ; Cherian, AM; Kanagasbapathy, AS; Seshadri, MS; Sud, A; Thomas, J | 1 |
| Bermúdez, JA; Fonseca, ME; Morán, C; Ochoa, R; Tena, G; Zárate, A | 1 |
| Bednarek-Tupikowska, G; Bohdanowicz-Pawlak, A; Bolanowski, M; Jedrzejak, JA; Lancranjan, I; Milewicz, A | 1 |
| Allen, SH; Braun, AL; McMurray, RW; Rodriguez, F; Walker, SE | 1 |
| Mierzejewski, W; Puzio, M; Rogoza, A | 1 |
| Pan, JT; Yang, JY | 1 |
| Atasü, T; Biberoğlu, K; Kandemir, O; Shabgahi, B | 1 |
| Avataneo, T; Camanni, F; Ciccarelli, E; Grottoli, S; Lancranjan, I; Miola, C | 1 |
| Gunaratne, M | 1 |
| Alarcón-Segovia, D; Cárdenas, R; Díaz-Sánchez, V; Larrea, F; López-Karpovitch, X; Piedras, J; Valencia, X | 1 |
| Aisaka, K; Kaneda, S; Kokuho, K; Mori, H; Saitoh, H; Tamechika, S; Toriya, Y; Tsuzuki, H; Yoshida, K | 1 |
| Foy, PM; Hughes, HJ; Jones, B; MacFarlane, IA; Petterson, T; Shaw, D | 1 |
| Lox, CD; Pau, KY | 1 |
| Bucht, E; Hulting, AL; Isberg, B; Sjöberg, HE; Tørring, O | 1 |
| Sarapura, V; Schlaff, WD | 1 |
| Asukai, K; Minaguchi, H; Uemura, T | 1 |
| Carballar, G; Espinosa de los Monteros, A; Obeid Layon, J; Parra Covarrubias, A | 1 |
| Cavanah, SF; Dons, RF | 1 |
| Dolecek, R; Lancranjanová, I; Putz, Z; Vavros, D; Závada, M | 1 |
| Andoh, K; Ibuki, Y; Itoh, M; Kawakami, Y; Mizunuma, H; Yamada, K | 1 |
| Durelle, G; Fuseau, A; Lombertie, ER | 1 |
| Colombo, N; D'Alberton, A; de Vincentiis, S; Marchini, M; Motta, T | 1 |
| Crosignani, PG; Ferrari, C; Piscitelli, G | 1 |
| Kawano, M; Kishimoto, T; Masuda, C; Nishisaka, N; Sakakura, T; Tsujino, T; Yasumoto, R | 1 |
| Webster, J | 1 |
| Choudhury, SD; Goswami, A | 1 |
| Di Gesù, I; Diaferia, A; Loizzi, P; Nicastri, PL; Tartagni, M | 1 |
| Holt, RI; Williams, TD | 1 |
| Heinonen, PK; Rossi, AM; Vilska, S | 1 |
| Gharbi, MH; Hafidi, A; Kadiri, A | 1 |
| Barth, JH; Belchetz, PE; Bridges, LR; McNichol, AM; Page, MD | 1 |
| Besser, GM; Grossman, AB; Jain, A; Jenkins, PJ; Jones, SL | 1 |
| Bishop, W; Hernández-Yañez, L; Marín-López, G; Torres-Morales, A; Vílchez-Martínez, J | 1 |
| Gerl, H; Knappe, G; Lehmann, R; Puhlmann, B; Rohde, W; Ventz, M | 1 |
| Berezin, M; Maor, Y | 1 |
| Chou, CT; Huang, CM | 1 |
| Aono, T; Azuma, K; Irahara, M | 1 |
| Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME | 1 |
| Barbosa-Coutinho, LM; Oliveira, MC; Pavanato, MA; Reis, FM; Ribeiro, MF; Silva, IS; Spritzer, PM | 1 |
| Asensio Egea, L; Hita Rosino, E; Hita Villaplana, G; López Cubillana, P; Rigabert Montiel, M; Server Falgás, G; Server Pastor, G | 1 |
| Pullan, PT; Walsh, JP | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Facciolli, G; Klain, M; Landi, ML; Lombardi, G; Panza, N; Pivonello, R; Salvatore, M | 1 |
| Conner, P; Fried, G | 1 |
| Colao, A; De Rosa, M; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Merola, B; Paesano, L; Zarrilli, S | 1 |
| Foppiani, L; Giusti, M; Guido, R; Sessarego, P | 1 |
| Greenman, Y; Stern, N; Tordjman, K | 1 |
| Chervin, A; Fideleff, HL; Gurucharri, C; Holland, ME; Sinai, I | 1 |
| Morrison, E | 1 |
| Andoh, N; Hirabuki, T; Hirahara, F; Minaguchi, H; Sawai, K; Uemura, T | 1 |
| Finkenstedt, G; Gasser, R; Höfle, G; Mohsenipour, I | 1 |
| Barri, PN; Dexeus, S | 1 |
| Ichihara, K; Kamei, H; Mizukoshi, K; Nagasaka, M; Okumura, K | 1 |
| Abram, F; Arvis, G; Chelbi, N; Kalfon, A; Linke, F; Tchovelidze, C | 1 |
| Deneux, C; Kuttenn, F; Mauvais-Jarvis, P; Plu-Bureau, G; Touraine, P | 1 |
| Bry-Gauillard, H; Kuttenn, F; Legendre, C; Mamzer-Bruneel, MF; Simoes-Vaz, A; Touraine, P | 1 |
| Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Torii, R | 1 |
| Bolton, CH; Fahy, U; Hartog, M; Hopton, MI; Hull, MG | 1 |
| Feldkamp, J; Höppner, W; Neumann, NJ; Schock-Skasa, G; Schuppe, HC | 1 |
| Carranza-Lira, S; González-Sánchez, JL; Martínez-Chequer, JC | 1 |
| Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J | 1 |
| Ito, M; Tamaya, T | 1 |
| Dilouya, A; Nataf, F; Piketty, ML; Roux, FX | 1 |
| Chang, LL; Chen, JJ; Chiao, YC; Huang, WJ; Kan, SF; Kau, MM; Lin, H; Lo, MJ; Tsai, SC; Wang, JL; Wang, PS; Wun, WS; Yeh, JY | 1 |
| De Nicolao, G; Faglia, G; Liberati, D; Pizzocaro, A; Sartorio, A; Veldhuis, JD | 1 |
| Kolarov, G; Marinov, B; Tsankova, M | 1 |
| al-saber, F; Culliton, M; Cunningham, S; Fiad, T; Hayes, F; McKenna, TJ; Suliman, AM | 1 |
| Golbert, L; Micheletto, C; Oliveira, MC; Pizarro, CB | 1 |
| Weiss, DK | 1 |
| Kamihigashi, S; Kawano, Y; Miyakawa, I; Nakamura, S | 1 |
| Chazova, IE; Dmitriev, VV; Masenko, VP; Mychka, VB | 1 |
| Krishnamra, N; Limlomwongse, L; Piyabhan, P | 1 |
| Pi, X; Voogt, JL | 1 |
| Beji, C; Kuttenn, F; Mauvais-Jarvis, P; Plu-Bureau, G; Touraine, P | 1 |
| Tollin, SR | 1 |
| MohanKumar, PS; MohanKumar, SM; Quadri, SK; Voogt, JL | 1 |
| De Santis, L; Doldi, N; Ferrari, A; Papaleo, E | 1 |
| Açbay, O; Demir, G; Gazioglu, N; Gundogdu, S; Kadioglu, P | 1 |
| Chen, X; Liu, J; Wang, J | 1 |
| De Seta, F; Giolo, E; Guaschino, S; Nucera, G; Pozzobon, C; Ricci, G | 1 |
| Brabant, G; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A | 1 |
| Inada, Y; Kojima, M; Komatsu, H; Miyata, H; Moro, M; Tsujii, H | 1 |
| Kajimura, T; Satoh, H; Taya, K; Watanabe, G | 1 |
| Arikan, E; Hatemi, H; Sabuncu, T; Tasan, E | 1 |
| Hagiwara, Y; Iwatsuki, K; Kadota, T; Moriuchi, S; Nakagawa, H; Yamada, M | 1 |
| Cappabianca, P; Colao, A; Di Salle, F; Di Sarno, A; Di Somma, C; Faggiano, A; Landi, ML; Lombardi, G; Pivonello, R; Rossi, FW | 1 |
| Arscott, GD; Craig, HR; Gabay, L | 1 |
| Cai, P; Dai, J; Pan, L; Wang, B; Wang, E; Zhang, N; Zhang, W | 1 |
| Casanueva, F; Dieguez, C; Doknic, M; Medic-Stojanoska, M; Pekic, S; Popovic, V; Zarkovic, M | 1 |
| Bartholini, F; Casti, P; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Modena, G; Portioli, I | 1 |
| Henderson, AH; Lewis, MJ | 1 |
| Meuwissen, JH; Pol, M | 1 |
| Janik, J; Jeske, W; Makowska, A; Słowinska-Srzednicka, J; Walecki, J; Zgliczyński, S; Zgliczyński, W | 1 |
| Blackwell, RE | 1 |
| Brownell, J; Lappöhn, RE; van de Wiel, HB | 1 |
| Smith, S | 1 |
| Chiarini, V; Cremonini, N; Graziano, E; Sforza, A; Zampa, GA | 1 |
| Alarcón-Segovia, D; Guadarrama, F; Larrea, F; Llorente, L; Méndez, JB; Vidaller, A; Villa, AR | 1 |
| Agnoli, AL; Bauer, T; Fassbender, WJ; Federlin, K; Hildebrandt, G; Mueller, HW; Roosen, K; Stracke, H | 1 |
| Pawlikowski, M; Pisarek, H; Stepien, H | 1 |
| Cortesi, L; Gherardi, F; Gianola, D; Lancranjan, I; Mazzocchi, N; Montini, M; Pagani, G; Pagani, MD; Pedroncelli, A; Tengattini, F | 1 |
| Aisaka, K; Mori, H; Yoshida, K | 1 |
| Ampudia, X; Calaf-Alsina, J; Corcoy, R; Espinós, JJ; Puig-Domingo, M; Schwarzstein, D; Webb, SM | 1 |
| Amato, G; Carella, C; Costagliola, C; Mastropasqua, L | 1 |
| Gerhard, I; Matt, O; Runnebaum, B | 1 |
| Boisvert, P; Brisson, GR; Gareau, R; Péronnet, F | 1 |
| Ginsburg, J; Hardiman, P; Thomas, M | 2 |
| Lin, SQ | 1 |
| Ando, N; Gorai, I; Hirabuki, T; Hirahara, F; Minaguchi, H; Onose, R | 1 |
| Okorokov, AN | 1 |
| Althoff, PH; Rau, H; Schmidt, K; Usadel, KH | 1 |
| Pisarek, H; Stepien, H | 1 |
| Kovács, I | 1 |
| Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G | 1 |
| Mangurian, LP; Posner, BI; Walsh, RJ | 1 |
| Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A | 1 |
| Hattori, N; Hino, M; Ikekubo, K; Ishihara, T; Kurahachi, H; Moridera, K | 1 |
| Müller, OA; von Werder, K | 1 |
| Brownell, J; de Wit, W; Rolland, R; Schoemaker, J; van der Heijden, PF | 1 |
| Besser, GM; Froud, AL; Grossman, AB; Touzel, R; Verhelst, JA; Wass, JA | 1 |
| Philosophe, R; Seibel, MM | 1 |
| Kawano, T; Kuroda, S; Yonekawa, Y | 1 |
| Castro, RC; Lengyel, AM; Moraes, CR; Mussio, W; Portes, E; Weingrill, CO | 1 |
| Matsuoka, R; Mori, H | 1 |
| Aronzon, R; Dorevitch, A; Stark, M | 1 |
| Imai, Y; Ozawa, Y; Sawano, S; Shimizu, T; Shishiba, Y; Watanabe, T | 1 |
| de March, A; Flamigni, C; Frank, G; Jasonni, VM; Raffelli, R | 1 |
| Ichikawa, Y; Usuki, S | 1 |
| Brabant, G; Hesch, RD; Lancranjan, I; Schulz, A; Schuppert, F; Schürmeyer, T; von zur Mühlen, A | 1 |
| Cappi, MP; Cortesi, L; Gherardi, F; Gianola, D; Lancranjan, I; Montini, M; Pagani, G; Pagani, MD; Pedroncelli, A; Tengattini, F | 1 |
| Dokumov, SI; Georgiev, DB | 1 |
| Goriaĭnova, II; Levitskaia, ZI; Sycheva, EA | 1 |
| Farkas, M; Tárczy, C; Tóth, E | 1 |
| Briganti, F; Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G | 1 |
| Govindarajulu, P; Gunasekar, PG; Kumaran, B | 1 |
| Buskila, D; Shoenfeld, Y; Sukenik, S | 1 |
| Alagna, S; Cavagnini, F; Ginanni, A; Lancranjan, I; Maraschini, C; Masala, A; Moro, M; Rovasio, PP; Toja, P | 1 |
| Buntner, B; Ostrowska, Z; Zwirska-Korczala, K; Zych, F | 1 |
| Cano López, H | 1 |
| Burdina, LM; Egorova, EB; Kononova, EF; Prilepskaia, VN; Vaskakova, LA | 1 |
| Goto, I; Harada, M; Kira, J; Shida, N; Yamaguchi, Y | 1 |
| Ge, QS; Gu, CX; Lin, SQ; Wang, HL; Xu, L | 1 |
| Bonfiglio, TA; Huang, KE; Muechler, EK | 1 |
| Mason, TC | 1 |
| Arita, K; Hirohata, T; Kurisu, K; Mukada, K; Onda, J; Takechi, A; Uozumi, T; Yano, T | 1 |
| Kichikhanov, SSh; Lapaeva, EV; Markovskiĭ, VN; Pamfamirov, IuK | 1 |
| Abbasi, A; Ataya, K; Kartaginer, J; Mercado, A | 1 |
| Brownell, J; Homburg, R; Jacobs, HS; West, C | 1 |
| Rasmussen, C | 1 |
| Lamberts, SW; Quik, RF | 1 |
| Adashi, EY; Hassell, A; Katz, E; Schran, HF; Weiss, BE | 1 |
| Alieva, EA; Ovsiannikova, TV; Pshenichnikova, TIa | 1 |
| Buskila, D; Holcberg, G; Horowitz, J; Sukenik, S | 1 |
| Avidan, D; Baron, E; Berezin, M | 1 |
| Boersma, A; Descamps, Y; Petit, S; Ponte, C; Racadot, A; Stuckens, C; Weill, J | 1 |
| Cohen, MJ; Holroyd, S | 1 |
| Tan, SL | 1 |
| Haider, P | 1 |
| Avril-Ducarne, C; Bastit, P; Bisson, JP; Cossec, A; Kuhn, JM; Wolf, LM | 1 |
| Tan, LG; Tan, SA | 1 |
| Diop, AG; Gueye, M; Kabre, A; Mauferon, JB; Ndiaye, IP; Ndiaye, MM | 1 |
| Afonina, LI; Ataniiazova, OA; Orlova, VG; Smetnik, VP | 1 |
| Blecha, F; Klemcke, HG; Nienaber, JA | 1 |
| Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Miletto, P; Schettini, G | 1 |
| Bergh, T; Larsson, SG; Rasmussen, C | 1 |
| Bohnker, BK; Clark, JB; Hayes, GB; Morey, WA | 1 |
| Boulanger, JC | 1 |
| Breen, K; Leone, F; Swartz, CM | 1 |
| Dominoni, P; Ferrari, L; Gianola, D; Gualteroni, L; Montini, M; Pagani, G; Pagani, MD; Sileo, F; Stroppa, S; Tengattini, F | 1 |
| Aguilar, E; Pinilla, L; Rodríguez-Padilla, ML | 1 |
| Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Liubimov, AV | 1 |
| Bertoli, P; Cipriani, R; Peserico, A; Ruzza, G; Veller Fornasa, C | 1 |
| Crockford, PM; Cumming, DC | 1 |
| Caterson, I; Fraser, IS; Herington, AC; Lun, ZG; Markham, R; McCarron, G; Tan, K; Zhou, JP | 1 |
| Caplan, RM; Leshin, B; Piette, WW | 1 |
| Camanni, F; Ciccarelli, E; Giordano, G; Giusti, M; Miola, C; Potenzoni, F; Sghedoni, D | 1 |
| Hurley, AM; Kleinberg, DL; Newman, CB | 1 |
| Balabolkin, MI; Gerasimov, GA; Gorokhova, TR; Snigireva, RIa | 1 |
| Avataneo, T; Besser, GM; Camanni, F; Ciccarelli, E; Grossman, A; Miola, C | 1 |
| Burdina, LM; Korneeva, IE; Ovsiannikova, TV; Pshenichnikova, TIa | 1 |
| Kanchaveli, ZSh; Kurashvili, RB; Sabakhtarashvili, MA; Veĭnberg, EG | 1 |
| Catalan, J; Harrison, P; McCann, J; Strangeway, P | 1 |
| Devi, GU; Govindappa, S; Prasad, M | 1 |
| Liashko, ES; Ovsiannikov, TV; Pshenichnikova, TIa; Shchedrina, RN; Speranskaia, NV | 1 |
| Usuki, S; Usuki, Y | 1 |
| Falsetti, L; Gastaldi, A; Pasinetti, E; Schivardi, MR | 1 |
| Minakami, H; Satoh, T; Tamada, T; Tamura, T | 1 |
| Kimura, T; Kondo, I; Masahashi, T; Matsuzawa, K; Mizutani, S; Narita, O; Osawa, M; Suganuma, N; Tomoda, Y | 1 |
| Aguiló, F; Baco, F; Otero, JR | 1 |
| Casper, RF; Gonen, Y | 1 |
| al-Suleiman, SA; Najashi, S; Rahman, J; Rahman, MS | 1 |
| Cowan, BD; Norman, PF; Sopelak, VM; Whitworth, NS | 1 |
| Austin, KL | 1 |
| Minagawa, F; Nakabayashi, H; Takeda, R | 1 |
| Hirai, M; Ikawa, G; Matsuoka, I; Miyake, M; Nakai, T | 1 |
| Bernstein, J; Buckman, MT; Mattox, JH | 1 |
| Asnis, G; Gioia, P | 1 |
| Cowan, BD; Kahlstorf, JH; Lucas, JA | 1 |
| Abbasi, A; Ataya, K; Kartaginer, J; Mercado, A; Moghissi, KS | 1 |
| Czeizel, A; Gláz, E; Kiss, R; Mohori, K; Rácz, K | 1 |
| Kletzky, OA; Vermesh, M | 1 |
| Daru, J; Godó, G; Koloszár, S; Sas, M; Szilágyi, I | 1 |
| Bunatian, AF; Dedov, II; Ermolenko, VM; Kukhtevich, AV; Kuznetsova, AI | 1 |
| Balan, VE; Butareva, LB; Smetnik, VP | 1 |
| Golubev, VA; Pamfamirov, IuK; Semeniuta, AN; Zaets, VV | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Xu, L | 1 |
| Kovneeva, IE; Ovsiannnikova, TV; Pshchenichnikova, TIa | 1 |
| Chrousos, GP; Cutler, GB; Loriaux, DL; Schiebinger, RJ | 1 |
| Adler, RA; Brinck-Johnsen, T; Herzberg, VL; Sokol, HW | 1 |
| Bartke, A; Klemcke, H; Matt, K | 1 |
| Tolstoi, LG | 1 |
| Kinouchi, T; Shimizu, N; Takeda, F; Yoshida, H | 1 |
| Arita, J; Kimura, F | 1 |
| Debski, R; Marianowski, L | 1 |
| Dluhy, RG | 1 |
| Heikkinen, J; Kauppila, A; Viinikka, L | 1 |
| Borenstein, R; Kletzky, OA; Mileikowsky, GN | 1 |
| Ambrosi, F; Fedeli, L; Filipponi, P; Giammartino, C; Nicoletti, I; Santeusanio, F; Spinozzi, F | 1 |
| Aisaka, K; Ando, S; Kokubo, K; Mori, H; Yoshida, K | 1 |
| Corenblum, B; Taylor, PJ | 1 |
| Gerli, R; Migliorati, G; Nicoletti, I; Orlandi, S; Rambotti, P; Riccardi, C | 1 |
| Heidvall, K; Hulting, AL | 1 |
| Aisaka, K; Ando, S; Kaneda, S; Kokuho, K; Mori, H; Tawada, T; Yoshida, K | 1 |
| Perić, LA; Prelević, GM; Würzburger, MI | 1 |
| Ganti, S; Goldman, M; Steinberger, A | 1 |
| Schindler, AM | 1 |
| Crowley, WR; Grosvenor, CE; Shah, GV; Shyr, SW | 1 |
| Barltrop, D; Gilbertson, N; Hardy, M; O'Connell, J | 1 |
| Glazener, CM; Hull, MG; Kelly, NJ | 1 |
| Benavides, S; Cortés-Gallegos, V; Hernández Bueno, JA; Porias Cuéllas, HL; Villanueva, C | 1 |
| Blau, RA; Kolb, FO; Lindberg, JS; Powell, MR | 1 |
| el-Beheiry, A; el-Kamshoushi, A; el-Sabah, K; Hussein, S; Souka, A | 1 |
| Baroldi, P; Cavioni, V; Crosignani, PG; Ferrari, C; Galparoli, C; Gerevini, G; Mattei, AM; Paracchi, A; Romano, C; Spellecchia, D | 1 |
| Alagna, SW; Hamilton, JA; Koppelman, MC; Loriaux, DL; Parry, BL | 1 |
| Astorga Jiménez, R; García-Luna, PP; Leal-Cerro, A | 1 |
| Atkinson, AB; Harley, JM; Sheridan, B; Traub, AI; Wilson, JM | 1 |
| Bieglmayer, C; Csaicsich, P; Deutinger, J; Reinthaller, A | 1 |
| Marut, EL; Schneider, AB; Scoccia, B; Scommegna, A | 1 |
| Harrison, RF | 1 |
| Cirillo, S; Fariello, C; Fusco, R; Lancranjan, I; Lombardi, G; Merola, B; Miletto, P; Schettini, G | 1 |
| Lamberts, SW | 1 |
| Lamberts, SW; Van Cutsem, EJ | 1 |
| Maleeva, A; Tanchev, S; Visheva, N | 1 |
| Aksu, F; Atasü, T; Kösebay, D | 1 |
| Fava, GA | 1 |
| Aruldhas, MM; Govindarajulu, P; Gunasekar, PG; Kumaran, B | 1 |
| Chan, T; Lam, KS; Liu, MY; Ma, JT; Wang, C; Yeung, RT | 1 |
| Imai, T; Miura, K; Ohta, T; Yasuda, K | 1 |
| Kato, K; Seki, K | 2 |
| Minisci, N; Negri, P; Pittini, L | 1 |
| Chimbira, TH; Kasule, J | 1 |
| Baird, DT; Glasier, AF; Hendry, RA; Seth, J | 1 |
| del Pozo, E; Falaschi, P; Rocco, A | 1 |
| Kato, K; Seki, K; Shima, K | 1 |
| Weil, C | 1 |
| Baldini, A; Carani, C; Cavicchioli, C; Marrama, P; Piccinini, D; Zini, D | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Elkind-Hirsch, KE; Platia, MP; Schiff, I | 1 |
| Darbois, Y; de Gennes, JL; Metzger, J; Scherrer, H; Turpin, G | 1 |
| Tscherne, G | 1 |
| Fardella, CB; López, JM | 1 |
| Mahomed, K | 1 |
| Andreis, M; Camanni, F; Ciccarelli, E; Ghigo, E; Lancranjan, I; Massara, F; Mazza, E | 1 |
| Garner, PR; Hughes, EG | 1 |
| Atkinson, B; Barton, D; Gordon, D; Hadden, D; Harley, G; Kennedy, L; Maguiness, S; Sheridan, B; Traub, A | 1 |
| Barberis, A; Camanni, F; Ciccarelli, E; Ghigo, E; Guidoni, F; Massara, F; Mazza, E | 1 |
| Melzer, H | 1 |
| Osenin, AA; Ovsiannikova, TV; Pshenichnikova, TIa; Speranskaia, NV | 1 |
| Randolph, JF; Riddick, DH; Soto-Albors, CE; Ying, YK | 1 |
| Amoroso, S; Annunziato, L; Colace, G; Di Renzo, GF; Montemagno, U; Nappi, C; Taglialatela, M | 1 |
| Csaba, IF; Nagy, P; Szilágyi, A | 1 |
| Bergh, T; Rasmussen, C; Wide, L | 1 |
| Krupp, P; Monka, C | 1 |
| Besser, M; Grossman, A; Wass, JA | 1 |
| Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 1 |
| Blackwell, RE; Chang, RJ | 1 |
| Csaba, I; Nagy, P; Szilágyi, A | 1 |
| Greenspan, SL; Klibanski, A; Neer, RM; Ridgway, EC | 1 |
| Frohman, LA; Torres-Noriega, J | 1 |
| Ruíz-Velasco, V | 1 |
| Cernuto, A; Iachello, R; Montoneri, C; Panella, M; Pepe, F; Sanfilippo, A | 1 |
| Cocores, JA; Dackis, CA; Gold, MS | 1 |
| Barzilai, D; Ben-Haim, S; Hochberg, Z; Ish-Shalom, S | 1 |
| Bol'shakova, TD; Gitel', EP; Lukovnikova, LP; Podzolkov, VI; Ziabreva, EV | 1 |
| Witten, BI | 1 |
| Barbieri, C; Boghen, M; Caldara, R; Codecasa, F; Dubini, A; Ferrari, C; Mucci, M; Paracchi, A; Romano, C | 1 |
| Jacobs, HS; Morris, D; Tan, SL | 1 |
| Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D | 1 |
| Godó, G; Koloszár, S; Sas, M | 2 |
| Borowicz, C; Postawski, K; Przylepa, M; Rechberger, T | 1 |
| Karavagul, C; Makemaharn, O; Ongsangkul, T; Srivannaboon, S; Tungsubutara, V | 1 |
| Arvas, M; Atasü, T; Kösebay, D | 1 |
| Desch, G; Descomps, B; du Cailar, J; Jullien, Y; Rochette, A | 1 |
| Magyar, DM | 1 |
| Buvat, J; Dewailly, D; Fossati, P; Fourlinnie, JC; Lemaitre, G; Mazzuca, M; Thomas, P; Wemeau, JL | 1 |
| Rachev, E; Spasov, S | 1 |
| Melzer, H; Uhlmann, G | 1 |
| Adams, J; Franks, S; Mason, H; Polson, D | 1 |
| Caraceni, MP; Casazza, S; Corghi, E; D'Alberton, A; Motta, T; Ortolani, S | 1 |
| Ge, QS; Gu, CX; Lin, SQ; Shi, YF; Wang, HL; Xie, YZ; Xu, L; Xu, YD; Yu, KM; Zang, X | 1 |
| Evans, WS; Hellmann, P; Kovacs, K; McComb, DJ; Scott, D; Thorner, MO | 1 |
| König, MP; Kopp, P | 1 |
| Schlechte, JA | 1 |
| Brabant, G; Brennecke, I; Friedrich, H; Herrmann, H; Hesch, RD; von zur Mühlen, A; Wagner, TO | 1 |
| Brust, J; Cohn, JB; DiSerio, F; Singer, J | 1 |
| Keller, E; Litschgi, M | 1 |
| Boulanger, CM; Chang, RJ; Mashchak, CA | 1 |
| Mattox, JH | 1 |
| Buvat, J; Buvat-Herbaut, M; Fossati, P; Fourlinnie, JC; Lemaire, A; Racadot, A | 1 |
| del Pozo, E | 1 |
| Strauch, G | 1 |
| Bourdelle-Hego, MF; Buvat, J; Clarisse, J; Dewailly, D; Fermon, C; Fossati, P; Lemaire, A; Lemaitre, G; Pouyol-Motte, H; Thomas-Desrousseaux, P | 1 |
| Mauvais-Jarvis, P | 1 |
| De Leon, FD | 1 |
| Schneider, HP | 1 |
| Abe, J; Hirose, T; Kimura, J; Okada, H; Tamaya, T | 1 |
| Dedov, II; Ermolenko, VM; Gitel', EP; Kukhtevich, AV; Mel'nichenko, GA | 1 |
59 review(s) available for bromocriptine and Hyperprolactinemia
| Article | Year |
|---|---|
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus.
Topics: Bromocriptine; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Parkinson Disease; Restless Legs Syndrome | 2022 |
Bromocriptine therapy: Review of mechanism of action, safety and tolerability.
Topics: Acromegaly; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 2022 |
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
Topics: Bromocriptine; Cabergoline; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 2022 |
Metabolic effects of prolactin.
Topics: Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Glucose; Humans; Hyperprolactinemia; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin; Receptors, Dopamine; Receptors, Prolactin; Testosterone; Weight Gain | 2022 |
The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperprolactinemia; Pituitary Neoplasms | 2023 |
How to manage intolerance to dopamine agonist in patients with prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2023 |
ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
Topics: Acromegaly; Animals; Anniversaries and Special Events; Antiparkinson Agents; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Drug Discovery; Drug Therapy, Combination; Ergotism; History, 20th Century; Hormone Antagonists; Humans; Hyperprolactinemia; Hypoglycemic Agents; Parkinson Disease; Pituitary Neoplasms | 2018 |
Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?
Topics: Arthritis, Rheumatoid; Autoimmunity; Breast Feeding; Bromocriptine; Female; Humans; Hyperprolactinemia; Infant; Infant Health; Infant, Newborn; Lupus Erythematosus, Systemic; Milk, Human; Prolactin; Scleroderma, Systemic | 2019 |
[Endocrinologic diseases management during breastfeeding].
Topics: Breast Feeding; Bromocriptine; Contraindications; Diabetes Mellitus, Type 2; Diet, Diabetic; Dopamine Agonists; Endocrine System Diseases; Estrogens; Female; Humans; Hyperprolactinemia; Hypoglycemic Agents; Hypopituitarism; Infant; Infant, Newborn; Insulin; Lactation; Milk, Human; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Prolactin; Prolactinoma; Puerperal Disorders; Thyroid Diseases | 2015 |
Update on prolactinomas. Part 2: Treatment and management strategies.
Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus | 2015 |
Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history.
Topics: Abortion, Habitual; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Live Birth; Pregnancy; Randomized Controlled Trials as Topic | 2016 |
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Randomized Controlled Trials as Topic | 2011 |
Prolactinoma in pregnancy.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2011 |
Hyperprolactinemia: etiology, diagnosis, and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Neurosurgical Procedures; Prevalence | 2002 |
Dopamine agonist therapy for hyperprolactinemia.
Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles | 2003 |
Prolactin as a modulator of B cell function: implications for SLE.
Topics: Animals; B-Lymphocytes; Bromocriptine; Dopamine Agonists; Humans; Hyperprolactinemia; Immune Tolerance; Lupus Erythematosus, Systemic; Mice; Prolactin | 2004 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
Current treatment issues in female hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2006 |
Quinagolide--a valuable treatment option for hyperprolactinaemia.
Topics: Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Patient Compliance | 2006 |
[Chiari-Frommel syndrome].
Topics: Bromocriptine; Chiari-Frommel Syndrome; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Prognosis | 2006 |
[Amenorrhea-galactorrhea syndrome].
Topics: Amenorrhea; Bromocriptine; Dopamine Agonists; Female; Galactorrhea; Hirsutism; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Syndrome | 2006 |
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
Topics: Adenoma; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Prolactin; Prolactinoma; Sex Characteristics | 2006 |
Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Dopamine Antagonists; Drug Antagonism; Female; Haloperidol; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma; Schizophrenia | 2008 |
Hyperprolactinemia and prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2008 |
New drugs for hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Hormone Antagonists; Humans; Hyperprolactinemia | 1995 |
Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
Topics: Adolescent; Bromocriptine; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Male; Prolactin | 1995 |
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Prolactin; Tissue Distribution | 1995 |
Prolactin: a stimulator of disease activity in systemic lupus erythematosus.
Topics: Animals; Autoimmune Diseases; Bromocriptine; Disease Models, Animal; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Prolactin; Receptors, Prolactin | 1995 |
Recent advances in the understanding of the pathophysiology and treatment of hyperprolactinemia.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pergolide; Prolactin; Receptors, Dopamine D2; Signal Transduction; Treatment Outcome | 1993 |
McCune-Albright syndrome: how many endocrinopathies can one patient have?
Topics: Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Heart Failure; Humans; Hyperparathyroidism; Hyperprolactinemia; Hyperthyroidism; Iodine Radioisotopes; Middle Aged; Puberty, Precocious; Radiography | 1993 |
Cabergoline: a new drug for the treatment of hyperprolactinaemia.
Topics: Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Postpartum Period; Randomized Controlled Trials as Topic | 1995 |
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy | 1996 |
[Bromocriptine loading test].
Topics: Bromocriptine; Humans; Hyperprolactinemia; Pituitary Function Tests; Pituitary Gland, Anterior; Prolactin; Prolactinoma | 1997 |
Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin | 1998 |
Diagnosis and treatment of prolactinomas.
Topics: Bromocriptine; Female; Fetus; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Neurosecretion; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1999 |
Medical treatment of prolactinomas.
Topics: Animals; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Neurosecretory Systems; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 1999 |
Hyperprolactinemia. Evaluation and management.
Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Infertility; Ovary; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Pathologic hyperprolactinemia.
Topics: Bromocriptine; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Hypothalamo-Hypophyseal System; Male; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1992 |
[Hyperprolactinemia].
Topics: Bromocriptine; Dopamine Agents; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |
Novel approaches to the management of hyperprolactinemia.
Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Pergolide | 1991 |
The possible role of prolactin in autoimmunity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis | 1991 |
[Hyperprolactinemia. Study of a current topic].
Topics: Amenorrhea; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Gland, Anterior; Prolactin | 1991 |
Influence of pregnancy on the serum prolactin level following prolactinoma surgery.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Pituitary Gland; Postpartum Period; Pregnancy; Pregnancy Complications; Prolactin; Prolactinoma; Radioimmunoassay; Remission, Spontaneous; Retrospective Studies | 1991 |
Management of prolactinoma.
Topics: Bromocriptine; Humans; Hyperprolactinemia; Male; Osteoporosis; Pituitary Neoplasms; Prolactinoma | 1990 |
Hyperprolactinemia and the management of related tumors.
Topics: Bromocriptine; Clinical Trials as Topic; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Radiotherapy; Surgical Procedures, Operative; Tomography, X-Ray Computed | 1990 |
Bromocriptine in obstetrics and gynaecology.
Topics: Bromocriptine; Female; Genital Diseases, Female; Humans; Hyperprolactinemia; Lactation; Pregnancy | 1990 |
[Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Prolactinoma | 1989 |
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin; Prolactin Release-Inhibiting Factors; Thyrotropin-Releasing Hormone | 1986 |
Hyperprolactinemia in nonpregnant women due to pituitary tumors.
Topics: Adenoma; Amenorrhea; Animals; Bone Diseases; Bromocriptine; Circadian Rhythm; Dopamine; Estrogens; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Ovary; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Cell Surface; Receptors, Dopamine; Receptors, Prolactin; Thyrotropin-Releasing Hormone | 1986 |
[Drug and radiotherapy of pituitary tumors].
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Reserpine; Valproic Acid | 1986 |
[Selected problems related to the use of bromocriptine (parlodel) in obstetrics and gynecology].
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Mastitis; Pregnancy | 1988 |
Diagnosis and management of hyperprolactinemia.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Male; Pituitary Neoplasms; Prolactin | 1988 |
Pregnancy in the hyperprolactinaemic patient.
Topics: Adenoma; Animals; Bromocriptine; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Rats; Thyrotropin-Releasing Hormone | 1986 |
[Current problems of hyperprolactinemia. II. Selection and systematization of the treatment].
Topics: Bromocriptine; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Thyroidectomy | 1987 |
The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
Topics: Abnormalities, Drug-Induced; Adenoma; Bromocriptine; Endocrine Glands; Female; Humans; Hyperprolactinemia; Infant; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactin; Risk; Time Factors | 1986 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Amenorrhea, galactorrhea, and hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Empty Sella Syndrome; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothyroidism; Lactation Disorders; Male; Pituitary Neoplasms; Prolactin | 1985 |
[Modern drug treatment of hyperprolactinemia].
Topics: Animals; Bromocriptine; Clinical Trials as Topic; Ergot Alkaloids; Female; Humans; Hyperprolactinemia; Hypothalamus; Pregnancy; Prolactin; Rats; Time Factors | 1985 |
Ovulatory disorders in women with polycystic ovary syndrome.
Topics: Androgens; Anovulation; Bromocriptine; Chorionic Gonadotropin; Clomiphene; Diagnosis, Differential; Estrogens; Female; Follicle Stimulating Hormone; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Hirsutism; Humans; Hyperprolactinemia; Infertility, Female; Menotropins; Menstruation Disturbances; Obesity; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Ultrasonography | 1985 |
69 trial(s) available for bromocriptine and Hyperprolactinemia
| Article | Year |
|---|---|
The effects of combined bromocriptine and Bu-shen-zhu-yun decoction on serum hormones, anxiety, and pregnancy in hyperprolactinemic infertility patients.
Topics: Anxiety; Bromocriptine; Drugs, Chinese Herbal; Female; Humans; Hyperprolactinemia; Infertility, Female; Kisspeptins; Pregnancy; Pregnancy Rate; Prolactin; Sleep | 2021 |
[Qilin pills combined with bromocriptine for idiopathic hyperprolactinemic oligoasthenozoospermia].
Topics: Adult; Asthenozoospermia; Bromocriptine; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Hyperprolactinemia; Male; Oligospermia; Phytotherapy; Prolactin; Young Adult | 2013 |
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Topics: Adult; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Middle Aged; Prolactin; Risk Factors | 2015 |
Jasmine flower extract lowers prolactin.
Topics: Adolescent; Adult; Antipsychotic Agents; Bromocriptine; Cross-Over Studies; Double-Blind Method; Female; Flowers; Humans; Hyperprolactinemia; Jasminum; Middle Aged; Phytotherapy; Plant Extracts; Postpartum Period; Prolactin; Treatment Outcome | 2015 |
The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
Topics: Adult; Bromocriptine; China; Dopamine Agonists; Estradiol; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Postpartum Period; Pregnancy; Prolactin; Random Allocation; Secondary Prevention; Severity of Illness Index; Symptom Flare Up | 2015 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
Topics: Adolescent; Adult; Bromocriptine; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Infertility, Female; Male; Menstruation; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Prolactin; Prospective Studies; Young Adult | 2009 |
Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Female; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Hyperprolactinemia; Hypothalamo-Hypophyseal System; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Single-Blind Method | 2010 |
A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
Topics: Adult; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Insemination, Artificial | 2010 |
The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.
Topics: Adult; Aldosterone; Angiotensin II; Bromocriptine; Creatinine; Dopamine Agonists; Female; Humans; Hydrocortisone; Hyperprolactinemia; Prolactin; Radioimmunoassay; Renin; Renin-Angiotensin System; Sodium | 2011 |
[Efficacy of compound xuanju capsule combined with bromocriptine on hyperprolactinemia-induced erectile dysfunction].
Topics: Adult; Bromocriptine; Drug Therapy, Combination; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Phytotherapy | 2012 |
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstrual Cycle; Nitric Oxide; Ovulation; Pituitary Neoplasms; Progesterone; Prolactinoma; Reference Values | 2002 |
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Topics: Adult; Blood Glucose; Bromocriptine; C-Reactive Protein; Cholesterol; Endothelium, Vascular; Estrogens; Female; Fibrinogen; Glucose Tolerance Test; Homocysteine; Hormone Antagonists; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Premenopause; Prolactin; Uric Acid; Vasodilation | 2003 |
Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia.
Topics: Adult; Breast Diseases; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Pain; Phytotherapy; Prospective Studies | 2004 |
Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Prolactin; Psychotic Disorders; Sulpiride | 2004 |
Evaluation of a novel vaginal bromocriptine mesylate formulation: a pilot study.
Topics: Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Patient Satisfaction; Pilot Projects; Suppositories | 2005 |
[Comparative evaluation of effectiveness of treatment of hyperprolactinemia].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Ovulation; Pituitary Neoplasms; Treatment Outcome | 2007 |
Superiority of newly developed vaginal suppositories over vaginal use of commercial bromocriptine tablets: a randomized controlled clinical trial.
Topics: Acrylic Resins; Administration, Intravaginal; Adult; Bromocriptine; Dopamine Agonists; Double-Blind Method; Female; Humans; Hyperprolactinemia; Infertility, Female; Pilot Projects; Poloxamer; Prolactin; Suppositories; Treatment Outcome | 2007 |
Quality of life in women with microprolactinoma treated with dopamine agonists.
Topics: Adult; Antineoplastic Agents; Brazil; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Health Status Indicators; Humans; Hyperprolactinemia; Middle Aged; Multivariate Analysis; Pituitary Neoplasms; Prolactin; Prolactinoma; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome | 2008 |
Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
Topics: Adhesiveness; Administration, Buccal; Administration, Intravaginal; Bromocriptine; Dosage Forms; Down-Regulation; Egypt; Female; Hormone Antagonists; Humans; Hydrogen-Ion Concentration; Hyperprolactinemia; Pilot Projects; Poloxamer; Prolactin; Solubility; Surface Properties; Time Factors; Treatment Outcome; Young Adult | 2008 |
A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Bromocriptine; Drug Therapy, Combination; Drugs, Chinese Herbal; Estradiol; Female; Glycyrrhiza; Humans; Hyperprolactinemia; Oligomenorrhea; Paeonia; Phytotherapy; Plant Extracts; Progesterone; Prolactin; Risperidone; Schizophrenia; Testosterone | 2008 |
[Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Female; France; Humans; Hyperprolactinemia; Middle Aged; Prolactin; Prospective Studies | 1995 |
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine.
Topics: Administration, Oral; Adult; Aminoquinolines; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Drug Resistance; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Tomography, X-Ray Computed | 1994 |
[The effect of occult hyperprolactinemia (OHP) on gonadotropin secretion system].
Topics: Anovulation; Bromocriptine; Circadian Rhythm; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hyperprolactinemia; Retrospective Studies; Thyrotropin-Releasing Hormone | 1994 |
Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Tolerance; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies | 1994 |
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Ergolines; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin | 1994 |
The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Galactorrhea; Humans; Hyperprolactinemia; Injections, Intramuscular; Prolactin | 1993 |
Tolerability, safety and efficacy of two formulations of Parlodel--a slow release oral form (SRO) versus registered Parlodel capsules.
Topics: Administration, Oral; Adult; Bromocriptine; Capsules; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperprolactinemia; Treatment Outcome | 1994 |
Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Double-Blind Method; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged | 1994 |
[Therapeutic efficacy of vaginal administration of bromocryptin in patients with hyperprolactinemia].
Topics: Adult; Bromocriptine; Drug Evaluation; Female; Humans; Hyperprolactinemia; Infertility, Female; Menstruation Disturbances; Prolactinoma; Vagina | 1993 |
[Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Hyperprolactinemia; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 1995 |
[Using bromocriptine vaginally for the treatment of hyperprolactinemia].
Topics: Administration, Intravaginal; Administration, Oral; Adult; Bromocriptine; Cross-Over Studies; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Middle Aged | 1996 |
Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Hypotension; Male; Middle Aged; Nausea; Prednisolone; Vomiting | 1996 |
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
Topics: Adult; Aminoquinolines; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies | 1998 |
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
Topics: Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Ergolines; Follow-Up Studies; Hormones; Humans; Hyperprolactinemia; Libido; Male; Penile Erection; Prolactin; Semen; Time Factors | 1998 |
[Treatment of hyperprolactinemic amenorrhea with cabergoline].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agonists; Double-Blind Method; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Prolactin; Treatment Outcome | 1997 |
Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials.
Topics: Abortion, Habitual; Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pregnancy; Pregnancy Outcome; Recurrence | 1998 |
The lipoprotein profile of women with hyperprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Lipoproteins; Middle Aged; Prolactin | 1999 |
[Our experience in using bromocriptine-Richter in gynecology (a preliminary report)].
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Prolactin | 2000 |
[Clinical study on effect of Bushen Tiaogan Lianru recipe on hyperprolactinemia].
Topics: Adult; Bromocriptine; Drugs, Chinese Herbal; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Prolactin | 1998 |
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Topics: Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2001 |
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Retrospective Studies | 2001 |
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.
Topics: Adolescent; Adult; Basal Metabolism; Body Weight; Bromocriptine; Dopamine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Leptin; Male; Middle Aged; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma | 2002 |
New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Visual Fields | 1992 |
The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia.
Topics: Adult; Amenorrhea; Aminoquinolines; Bromocriptine; Depression; Dopamine Agents; Female; Humans; Hyperprolactinemia; Menstruation; Oligomenorrhea; Prolactin; Prospective Studies; Psychological Tests | 1992 |
Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperprolactinemia | 1992 |
[Value of the metoclopramide test in diagnosis of hormonal causes of female sterility].
Topics: Adult; Bromocriptine; Female; Gonadal Steroid Hormones; Humans; Hyperprolactinemia; Infertility, Female; Menstrual Cycle; Metoclopramide; Pregnancy; Prolactin; Retrospective Studies | 1992 |
CV 205-502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia.
Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Double-Blind Method; Drug Evaluation; Drug Tolerance; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstrual Cycle; Middle Aged; Patient Compliance; Prolactin | 1991 |
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
Topics: Adult; Aminoquinolines; Blood Pressure; Bromocriptine; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Female; Hormones; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Time Factors | 1991 |
Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia.
Topics: Administration, Oral; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Menstrual Cycle; Menstruation Disturbances; Ovulation; Prolactin; Radioimmunoassay | 1992 |
Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind study.
Topics: Adolescent; Adult; Bromocriptine; Double-Blind Method; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1991 |
Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Prolactin | 1991 |
A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Double-Blind Method; Female; Humans; Hyperprolactinemia; Iodine Radioisotopes; Menstruation; Middle Aged; Prolactin; Radioimmunoassay; Randomized Controlled Trials as Topic | 1990 |
Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy.
Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Menstruation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography; Sella Turcica | 1990 |
A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
Topics: Adult; Amenorrhea; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Radiography | 1991 |
Increased circulating levels of bromocriptine after vaginal compared with oral administration.
Topics: Administration, Oral; Bromocriptine; Female; Humans; Hyperprolactinemia; Kinetics; Prolactin; Vagina | 1991 |
Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR).
Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Visual Fields | 1990 |
Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Middle Aged; Prolactin | 1989 |
Effect of hydergine in hyperprolactinemia.
Topics: Adolescent; Adult; Anovulation; Bromocriptine; Dihydroergotoxine; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Prolactin; Random Allocation | 1989 |
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia.
Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Antagonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Pergolide; Prolactin; Prospective Studies; Random Allocation; Time Factors | 1986 |
Borderline hyperprolactinemia in infertile women: evaluation of the prolactin response to thyrotropin releasing hormone and double-blind placebo-controlled treatment with bromocriptine.
Topics: Adult; Bromocriptine; Double-Blind Method; Estradiol; Female; Humans; Hyperprolactinemia; Infertility, Female; Progesterone; Prolactin; Random Allocation; Thyrotropin-Releasing Hormone | 1987 |
Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Male; Middle Aged; Prolactin | 1988 |
Effect of bromocriptine on affect and libido in hyperprolactinemia.
Topics: Adult; Affect; Bromocriptine; Clinical Trials as Topic; Depression; Emotions; Female; Humans; Hyperprolactinemia; Libido; Orgasm; Prolactin; Psychiatric Status Rating Scales | 1987 |
Stress spikes of hyperprolactinaemia and infertility.
Topics: Adult; Bromocriptine; Clomiphene; Female; Humans; Hyperprolactinemia; Infertility, Female; Stress, Physiological | 1988 |
Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women.
Topics: Adult; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Nausea; Pregnancy; Puerperal Disorders; Vomiting | 1987 |
Bromocriptine inhibition of hyperprolactinemia during surgery.
Topics: Anesthesia, Intravenous; Bromocriptine; Clinical Trials as Topic; Female; Humans; Hyperprolactinemia; Intraoperative Complications; Preanesthetic Medication; Prolactin | 1985 |
Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin).
Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed | 1985 |
[Modern drug treatment of hyperprolactinemia].
Topics: Animals; Bromocriptine; Clinical Trials as Topic; Ergot Alkaloids; Female; Humans; Hyperprolactinemia; Hypothalamus; Pregnancy; Prolactin; Rats; Time Factors | 1985 |
324 other study(ies) available for bromocriptine and Hyperprolactinemia
| Article | Year |
|---|---|
Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.
Topics: Adult; Age Factors; Bromocriptine; Case-Control Studies; Comorbidity; Denmark; Dopamine Agonists; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Incidence; Registries; Risk Assessment; Risk Factors; Sex Factors; Time Factors | 2021 |
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Idiopathic granulomatous mastitis associated with hyperprolactinemia: A nonoperative approach.
Topics: Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Female; Granulomatous Mastitis; Humans; Hyperprolactinemia; Middle Aged | 2017 |
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide | 2017 |
Macroprolactinemia and Empty Sella Syndrome.
Topics: Bromocriptine; Dopamine Agonists; Empty Sella Syndrome; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin | 2017 |
The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.
Topics: Adult; Bromocriptine; Depression; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Prolactin; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Young Adult | 2018 |
Macroprolactinomas: longitudinal assessment of biochemical and imaging therapeutic responses.
Topics: Adult; Biomarkers, Tumor; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Tumor Burden; Young Adult | 2018 |
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2018 |
Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.
Topics: Adult; Age Factors; Biomarkers; Bromocriptine; Cardiovascular Diseases; Case-Control Studies; Dopamine Agonists; Dyslipidemias; Female; Fenofibrate; Humans; Hyperprolactinemia; Hypolipidemic Agents; Lipids; Middle Aged; Prolactin; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Young Adult | 2019 |
Hyperprolactinemia impairs object recognition without altering spatial learning in male rats.
Topics: Analysis of Variance; Animals; Bromocriptine; Discrimination, Psychological; Disease Models, Animal; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Hyperprolactinemia; Male; Maze Learning; Memory Disorders; Prolactin; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Space Perception | 2013 |
Giant macroprolactinoma and pregnancy.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Treatment Outcome | 2013 |
Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
Topics: Adult; Bromocriptine; Diagnostic Imaging; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pregnancy; Recurrence; Retrospective Studies; Thailand; Treatment Outcome | 2013 |
Prolactin regulates kisspeptin neurons in the arcuate nucleus to suppress LH secretion in female rats.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Estradiol; Female; Hyperprolactinemia; Immunohistochemistry; Kisspeptins; Luteinizing Hormone; Neurons; Phosphorylation; Prolactin; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sheep; STAT5 Transcription Factor | 2014 |
Women with prolactinomas presented at the postmenopausal period.
Topics: Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2014 |
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma | 2014 |
The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Glucose Intolerance; Humans; Hyperprolactinemia; Hypoglycemic Agents; Metformin; Pilot Projects; Prolactin | 2015 |
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
Efficacy and Mechanism of Action of Yiru Tiaojing Granule Against Hyperprolactinemia In Vitro and In Vivo.
Topics: Animals; Brain; Bromocriptine; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Haloperidol; Hyperprolactinemia; Medicine, Chinese Traditional; Progesterone; Prolactin; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2015 |
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Ergolines; Female; Health Care Costs; Hormone Antagonists; Humans; Hyperprolactinemia; Life Expectancy; Male; Medicare; Microsurgery; Middle Aged; Monte Carlo Method; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma; Quality-Adjusted Life Years; Sphenoid Sinus; Time Factors; Treatment Outcome; United States | 2016 |
Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Bromocriptine; Humans; Hyperprolactinemia; Male; Paliperidone Palmitate; Schizophrenia; Treatment Outcome; Tremor; Weight Gain | 2016 |
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2016 |
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2016 |
Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.
Topics: Adult; Breast Feeding; Bromocriptine; Cesarean Section; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Retrospective Studies; Withholding Treatment | 2017 |
Prolactin has a pathogenic role in systemic lupus erythematosus.
Topics: Adaptive Immunity; Animals; Antibodies, Antinuclear; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Immunity, Innate; Immunocompetence; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Pregnancy; Pregnancy Complications; Prolactin; Receptors, Prolactin | 2017 |
Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.
Topics: Adolescent; Adult; Aged; Brazil; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Retrospective Studies; Treatment Outcome | 2008 |
[Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Clomiphene; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Infertility, Female; Menotropins; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Prolactin; Retrospective Studies; Treatment Outcome | 2008 |
Dopamine agonists and hyperprolactinaemia.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia | 2009 |
Silymarin BIO-C, an extract from Silybum marianum fruits, induces hyperprolactinemia in intact female rats.
Topics: Animals; Body Weight; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Fruit; Hyperprolactinemia; Plant Extracts; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Reference Standards; Silybum marianum; Silymarin | 2009 |
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography | 2009 |
[Clinical and therapeutic particularities of depression associated with pituitary adenoma].
Topics: Adenoma; Adult; Bromocriptine; Depressive Disorder, Major; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms | 2009 |
Hyperprolactinemia: different clinical expression in childhood.
Topics: Adolescent; Amenorrhea; Bromocriptine; Child; Child, Preschool; Female; Humans; Hyperprolactinemia; Infant; Male; Polycystic Ovary Syndrome; Prolactinoma; Puberty, Delayed | 2010 |
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma | 2010 |
Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
Topics: Adult; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome | 2010 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Topics: Animals; Bromocriptine; Cell Line; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Estradiol; Female; Glycyrrhiza; Haloperidol; Herb-Drug Interactions; Hyperprolactinemia; Metoclopramide; Paeonia; PC12 Cells; Phytotherapy; Plant Extracts; Progesterone; Prolactin; Rabbits; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2012 |
Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.
Topics: Animals; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Ergolines; Female; Fertility; Gene Expression Regulation; Humans; Hyperprolactinemia; Infertility; Mice; Mice, Transgenic; Ovulation; Phenotype; Time Factors | 2012 |
Hyperprolactinemia in children: clinical features and long-term results.
Topics: Adolescent; Bromocriptine; Cabergoline; Child; Combined Modality Therapy; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome | 2012 |
Prolactin regulation of neonatal ovine uterine gland morphogenesis.
Topics: Aging; Animals; Animals, Newborn; Bromocriptine; DNA-Binding Proteins; Endometrium; Estradiol; Female; Hyperprolactinemia; In Situ Hybridization; Interferon Regulatory Factor-1; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morphogenesis; Phosphoproteins; Phosphorylation; Prolactin; Sheep; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Trans-Activators; Uterus | 2003 |
Del Castello syndrome--an unusual presentation.
Topics: Adult; Amenorrhea; Bromocriptine; Dopamine Agonists; Female; Galactorrhea; Humans; Hyperprolactinemia; Pregnancy; Syndrome | 2002 |
Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Topics: Adolescent; Bromocriptine; Dopamine Agonists; Growth Disorders; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma | 2004 |
Cardiopulmonary complications of ergot-derivative dopamine agonists.
Topics: Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Heart Valve Diseases; Humans; Hyperprolactinemia; Pergolide; Pulmonary Fibrosis; Risperidone | 2004 |
Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Drug Therapy, Combination; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Prolactin; Psychotic Disorders | 2005 |
[Verapamil-induced hyperprolactinemia--a case report].
Topics: Adult; Bromocriptine; Calcium Channel Blockers; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Prolactin; Time Factors; Verapamil | 2005 |
Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology.
Topics: Adult; Anticonvulsants; Brain; Bromocriptine; Encephalomalacia; Hormone Antagonists; Humans; Hyperprolactinemia; Infertility, Male; Lamotrigine; Magnetic Resonance Imaging; Male; Prolactin; Reproduction; Seizures; Triazines | 2005 |
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Fatty acid profiles in hepatic membranes of rats with different levels of circulating estrogen and prolactin.
Topics: Animals; Arachidonic Acid; Bromocriptine; Cell Membrane; Estrogens; Fatty Acids; Female; Hyperprolactinemia; Liver; Ovariectomy; Phospholipids; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Sprague-Dawley | 2007 |
Breastfeeding a baby with mother on Bromocripine.
Topics: Adult; Breast Feeding; Bromocriptine; Counseling; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Infant Nutritional Physiological Phenomena; Infant, Newborn; Pituitary Neoplasms; Prolactinoma | 2006 |
Galactorrhea in a 14-year-old girl.
Topics: Adolescent; Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma | 2006 |
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone | 2007 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat.
Topics: Animals; Body Weight; Bromocriptine; Eating; Female; Glycerolphosphate Dehydrogenase; Hormone Antagonists; Hyperprolactinemia; Hypothyroidism; Iodide Peroxidase; Lactation; Liver; Maternal Nutritional Physiological Phenomena; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Thyrotropin; Thyroxine; Triiodothyronine | 2008 |
[Follow-up of the effect of prolactin-lowering substances].
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lisuride; Menstruation; Prolactin | 1981 |
Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
[Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
Topics: Adult; Blood Glucose; Bromocriptine; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Female; Humans; Hyperprolactinemia; Infertility, Female; Prolactin | 1981 |
Effects of experimentally induced chronic hyperprolactinemia on the ultrastructure of pinealocytes in male rats.
Topics: Animals; Bromocriptine; Chronic Disease; Hyperprolactinemia; Male; Pineal Gland; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains | 1984 |
Prolactin receptor expression in lymphocytes from patients with hyperprolactinemia or acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; CD8-Positive T-Lymphocytes; Cells, Cultured; Down-Regulation; Flow Cytometry; Humans; Hyperprolactinemia; Lymphocyte Count; Lymphocytes; Middle Aged; Pituitary Neoplasms; Receptors, Prolactin | 1995 |
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Hypogonadism; Injections, Intravenous; Luteinizing Hormone; Metoclopramide; Naloxone; Narcotic Antagonists; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma | 1995 |
[Diagnostic and therapeutic approach to hyperprolactinemia].
Topics: Amenorrhea; Anovulation; Bromocriptine; Diagnostic Imaging; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstruation Disturbances; Pituitary Neoplasms; Prolactinoma | 1995 |
Bromocriptine for prolactinoma-related dissociative disorder and depression.
Topics: Bromocriptine; Depressive Disorder; Dissociative Disorders; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Neurocognitive Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
Prolactinomas: present day management.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1995 |
Endocrine assessment of impotence--pitfalls of measuring serum testosterone without sex-hormone-binding globulin.
Topics: Bromocriptine; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Menstrual Cycle; Pregnancy; Pregnancy Outcome; Prolactin; Prospective Studies | 1994 |
[Hyperprolactinemia: importance of early therapy].
Topics: Adenoma; Adult; beta-Endorphin; Bromocriptine; Cushing Syndrome; Female; Humans; Hyperprolactinemia; Neoplasm Recurrence, Local; Pituitary Neoplasms; Time Factors | 1994 |
The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine.
Topics: Adult; Amenorrhea; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Resistance; Drug Tolerance; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Prolactin | 1993 |
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting | 1993 |
Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy | 1994 |
Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide.
Topics: Acromegaly; Adult; Bromocriptine; Fibrous Dysplasia, Monostotic; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hyperprolactinemia; Injections, Subcutaneous; Insulin-Like Growth Factor I; Iodine Radioisotopes; Male; Octreotide; Prolactin; Somatostatin; Time Factors | 1994 |
Progress in the management of hyperprolactinemia.
Topics: Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia | 1994 |
Effects of bromocriptine (CB-154) treatment on copulatory behavior in hyperprolactinemic adult male rats.
Topics: Animals; Bromocriptine; Copulation; Hyperprolactinemia; Male; Pituitary Gland; Prolactin; Rats; Rats, Wistar | 1994 |
Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Kinetics; Prolactin | 1994 |
Hyperprolactinemia and hypogonadism.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypogonadism | 1993 |
Hyperprolactinemia in women--a series of 71 cases.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1993 |
Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Molecular Weight; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography | 1994 |
Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease.
Topics: Adult; Autoimmune Diseases; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactinoma; Radiography; Time Factors | 1994 |
[Detection and treatment of hyperprolactinemia in male infertility].
Topics: Adult; Bromocriptine; Circadian Rhythm; Humans; Hyperprolactinemia; Male; Oligospermia; Prolactin; Treatment Outcome | 1994 |
Enhanced tuberoinfundibular dopaminergic neuron activity in thyroidectomized, ovariectomized and estrogen-treated rats with hyperprolactinemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Cysteamine; Dopamine; Estrogens; Female; Hyperprolactinemia; Hypothalamus; Neurons; Ovariectomy; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Thyroidectomy; Thyroxine | 1994 |
Hyperprolactinaemia and reproductive failure.
Topics: Adolescent; Adult; Bromocriptine; Female; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Infertility, Female; Infertility, Male; Male; Menstruation Disturbances; Middle Aged; Prolactin; Treatment Outcome | 1993 |
Cellular and humoral immune parameters in women with pathological hyperprolactinemia before and during treatment with bromocriptine.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Immunoglobulins; Immunophenotyping; Lymphocyte Subsets | 1994 |
[A study with diagnostic standard of occult hyperprolactinemia (OHP) and the effect of bromocriptine administration].
Topics: Anovulation; Bromocriptine; Female; Humans; Hyperprolactinemia; Ovarian Function Tests; Prolactin; Reference Standards; Thyrotropin-Releasing Hormone | 1993 |
Hyperprolactinaemia and infertility following cranial irradiation for brain tumours: successful treatment with bromocriptine.
Topics: Adolescent; Brain Neoplasms; Bromocriptine; Cranial Irradiation; Female; Galactorrhea; Glioblastoma; Glioma; Humans; Hyperprolactinemia; Infertility, Female; Oligomenorrhea; Radiation Injuries | 1993 |
Beta-endorphin levels in women with elevated prolactin and following bromocriptine therapy.
Topics: Adult; beta-Endorphin; Bromocriptine; Female; Humans; Hyperprolactinemia; Prolactin | 1993 |
Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
Topics: Adult; Bone Density; Bromocriptine; Calcitonin; Calcium; Estradiol; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin-Like Growth Factor I; Lumbar Vertebrae; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Time Factors | 1993 |
Occult hyperprolactinemia in infertile women.
Topics: Adult; Bromocriptine; Corpus Luteum; Female; Galactorrhea; Humans; Hyperprolactinemia; Incidence; Infertility, Female; Luteal Phase; Prolactin; Reference Values; Thyrotropin-Releasing Hormone | 1993 |
[Parenteral, depot and repeatable forms of Parlodel LAR bromocriptine in the treatment of hyperprolactinemia syndrome. Comparison with oral Parlodel].
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Drug Implants; Female; Humans; Hyperprolactinemia; Injections | 1993 |
Assessment of the implantation site by transvaginal ultrasonography.
Topics: Adult; Bromocriptine; Embryo Implantation; Female; Gestational Age; Humans; Hyperprolactinemia; Infertility, Female; Menstrual Cycle; Ovarian Follicle; Ovulation; Pregnancy; Ultrasonography; Uterus; Vagina | 1993 |
Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Vagina | 1996 |
[A case of oligozoospermia with marginal hyperprolactinemia due to pituitary microadenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Oligospermia; Pituitary Neoplasms; Pregnancy | 1996 |
Hyperprolactinemia and reproductive disorders--a profile from north east.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Incidence; India; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1995 |
Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1995 |
Delayed puberty and reversible pituitary enlargement in a girl.
Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Growth Disorders; Hormone Antagonists; Humans; Hyperprolactinemia; Hypothyroidism; Puberty, Delayed; Tomography, X-Ray Computed | 1996 |
Outcome of pregnancies in women with treated or untreated hyperprolactinemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, Tubal | 1995 |
Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: an unusual acidophil stem cell adenoma.
Topics: Acromegaly; Adenoma, Acidophil; Adult; Bromocriptine; Female; Growth Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms | 1996 |
[Leydig cell function in hyper- or hypoprolactinemic states in healthy men].
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Estradiol; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Leydig Cells; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Prolactin; Reference Values; Secretory Rate; Sulpiride; Testosterone | 1996 |
[Pregnancy in hyperprolactinemic patients].
Topics: Adult; Breast Feeding; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1996 |
Hyperprolactinemia in postmenopausal women.
Topics: Adenoma; Aged; Bromocriptine; Dopamine Agonists; Female; Follow-Up Studies; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Postmenopause; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
Hyperprolactinemia in systemic lupus erythematosus.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Male; Middle Aged | 1997 |
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galactorrhea; Haloperidol; Humans; Hyperprolactinemia; Prolactin; Psychotic Disorders; Thioridazine | 1997 |
Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Topics: Animals; Bromocriptine; Estradiol; Female; Hyperprolactinemia; Organ Size; Ovariectomy; Pituitary Gland; Prolactin; Rats; Rats, Wistar | 1997 |
[Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
Topics: Adult; Bromocriptine; Dopamine Agonists; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma; Radiography | 1997 |
Hyperprolactinaemia in males: a heterogeneous disorder.
Topics: Adult; Aged; Bromocriptine; Follow-Up Studies; Hormone Antagonists; Humans; Hyperprolactinemia; Hypogonadism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1997 |
Dopaminergic modulation of hexarelin-induced GH and PRL secretion in hyperprolactinemia.
Topics: Adult; Bromocriptine; Dopamine; Female; Growth Hormone; Growth Substances; Humans; Hyperprolactinemia; Middle Aged; Oligopeptides; Prolactin | 1998 |
Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Regression Analysis; Retrospective Studies; Weight Gain | 1998 |
Analyzing amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypothalamus; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy Tests; Prolactinoma; Uterus | 1998 |
Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Male; Middle Aged; Nausea; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Prolactin; Prolactinoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Surgical Procedures, Operative; Treatment Outcome; Vision Disorders; Visual Fields | 1998 |
Hyperprolactinemia: an inductor of neoplastic changes in endometrium? A report of two cases.
Topics: Adenocarcinoma; Adult; Bromocriptine; Endometrial Neoplasms; Female; Humans; Hyperprolactinemia; Hysterectomy | 1998 |
Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
Topics: Animals; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Lisuride; Male; Rats; Rats, Wistar; Reserpine; Rotation; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics | 1998 |
[Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
Topics: Adult; Aged; Bromocriptine; Erectile Dysfunction; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged | 1998 |
Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperprolactinemia; Menopause; Middle Aged; Pituitary Neoplasms; Progestins; Prolactin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1998 |
Complete regression of a major hyperprolactinaemia after renal transplantation.
Topics: Adult; Bromocriptine; Drug Resistance; Humans; Hyperprolactinemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Remission Induction | 1999 |
New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.
Topics: Animals; Anovulation; Bromocriptine; Cabergoline; Callithrix; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Ergolines; Estradiol; Female; Hyperprolactinemia; Menstrual Cycle; Progesterone; Prolactin; Sulpiride; Time Factors | 1999 |
Secondary infertility as early symptom in a man with multiple endocrine neoplasia-type 1.
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Exons; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Multiple Endocrine Neoplasia Type 1; Mutation; Neoplasm Proteins; Oligospermia; Pituitary Neoplasms; Postoperative Period; Proto-Oncogene Proteins; Sperm Count | 1999 |
Vaginal bromocriptine administration in patients with hyperprolactinemia.
Topics: Administration, Intravaginal; Bromocriptine; Dopamine Agonists; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Prolactin; Treatment Outcome | 1999 |
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics | 1999 |
Unusual premature ovarian failure with hypogonadotropic hyperprolactinemia and 46, XX, 13ph+.
Topics: Adult; Amenorrhea; Bromocriptine; Chromosomes, Human, Pair 13; Clomiphene; Estrogen Antagonists; Estrogens; Female; Gonadotropins; Hormone Antagonists; Humans; Hyperprolactinemia; Menstruation; Pregnancy; Primary Ovarian Insufficiency; Ultrasonography | 1999 |
High prolactin level.
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Dopamine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Predictive Value of Tests; Prolactin; Prolactinoma | 2000 |
Direct effects of prolactin on corticosterone release by zona fasciculata-reticularis cells from male rats.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Animals; Bromocriptine; Cells, Cultured; Cerebral Cortex; Colforsin; Corticosterone; Cyclic AMP; Desoxycorticosterone; Hyperprolactinemia; Injections, Subcutaneous; Male; Nifedipine; Pituitary Gland, Anterior; Pregnenolone; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Sheep; Zona Fasciculata; Zona Reticularis | 1999 |
Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Topics: Adult; Amenorrhea; Bromocriptine; Case-Control Studies; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Prolactinoma; Secretory Rate; Statistics, Nonparametric | 2000 |
Hyperprolactinaemia: analysis of presentation, diagnosis and treatment in the endocrine service of a general hospital.
Topics: Bromocriptine; Combined Modality Therapy; Female; Hormone Antagonists; Hospitals, Teaching; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
[Hyperprolactinemia and psychological disturbance].
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bromocriptine; Case-Control Studies; Chi-Square Distribution; Depressive Disorder; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Interview, Psychological; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Risk Factors | 2000 |
Naval aviator with pituitary prolactin secreting microadenoma: case report and aeromedical concerns.
Topics: Adenoma; Adult; Aerospace Medicine; Bromocriptine; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Military Personnel; Pituitary Neoplasms; Prolactin | 2000 |
Delayed puberty associated with hyperprolactinemia caused by pituitary microadenoma.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Bone Density; Bromocriptine; Female; Follicle Stimulating Hormone; Hormone Antagonists; Human Growth Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Magnetic Resonance Imaging; Menarche; Ovulation; Pituitary Neoplasms; Puberty, Delayed; Thyrotropin | 2000 |
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Female; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypertension; Hypothalamo-Hypophyseal System; Pituitary Neoplasms; Pituitary-Adrenal System; Prolactin; Prolactinoma; Radioimmunoassay; Renin | 2000 |
Changes in the regulation of calcium metabolism and bone calcium content during growth in the absence of endogenous prolactin and during hyperprolactinemia: a longitudinal study in male and female Wistar rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Development; Bromocriptine; Calcium; Eating; Female; Hormone Antagonists; Hyperprolactinemia; Longitudinal Studies; Male; Pituitary Gland, Anterior; Pregnancy; Prolactin; Rats; Rats, Wistar | 2000 |
Mechanisms for suckling-induced changes in expression of prolactin receptor in the hypothalamus of the lactating rat.
Topics: Animals; Animals, Suckling; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Haloperidol; Hyperprolactinemia; Hypothalamus; Immunohistochemistry; Lactation; Neurons; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Prolactin | 2001 |
Long-term follow-up of 246 hyperprolactinemic patients.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Female; Follow-Up Studies; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Retrospective Studies | 2001 |
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Psychotic Disorders; Risperidone | 2000 |
Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Dopamine; Dopamine Agonists; Estrus; Female; Gene Expression; Hyperprolactinemia; Median Eminence; Neuronal Plasticity; Prolactin; Pseudopregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase | 2001 |
Treatment versus no treatment of transient hyperprolactinemia in patients undergoing intracytoplasmic sperm injection programs.
Topics: Adult; Bromocriptine; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Embryo Transfer; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Luteolytic Agents; Oocytes; Prolactin; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome; Triptorelin Pamoate | 2000 |
The effect of prolactin and bromocriptine on human peripheral immune status.
Topics: Adenoma; Adult; Bromocriptine; CD3 Complex; CD4-CD8 Ratio; CD56 Antigen; Female; Flow Cytometry; HLA-DR Antigens; Humans; Hyperprolactinemia; Killer Cells, Natural; Lymphocyte Subsets; Lymphocytes; Male; Pituitary Neoplasms; Prolactin; Receptors, IgG; Receptors, Interleukin-2 | 2001 |
Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature.
Topics: Adenoma; Administration, Intravaginal; Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy | 2001 |
[Reversible blindness caused by an invasive prolactinoma].
Topics: Acute Disease; Adult; Blindness; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma | 2001 |
Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
Topics: Animals; Anovulation; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Estrus; Female; Gonadotropins; Hormones; Hyperprolactinemia; Organ Transplantation; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2001 |
Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Female; France; Humans; Hyperprolactinemia; Menstruation Disturbances; Treatment Outcome | 2000 |
Effect of hyperprolactinemia induced by pituitary grafts or castration on porphyrin content of the mouse Harderian gland.
Topics: Animals; Body Weight; Bromocriptine; Butyrophenones; Disease Models, Animal; Female; Harderian Gland; Hormone Antagonists; Hyperprolactinemia; Male; Mice; Mice, Inbred Strains; Orchiectomy; Organ Size; Organ Transplantation; Pituitary Gland, Anterior; Porphyrins; Prolactin; Testis; Testosterone | 2001 |
Latent prolactinoma on MRI-selective venous sampling and trans-sphenoidal microsurgical treatment.
Topics: Adult; Bromocriptine; Catheterization, Central Venous; Diabetes Insipidus, Neurogenic; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Menstruation Disturbances; Neurosurgical Procedures; Pituitary Gland, Anterior; Postoperative Complications; Predictive Value of Tests; Prolactin; Prolactinoma; Sphenoid Bone; Treatment Outcome | 2001 |
Failure of bromocriptine therapy to control juvenile mammary hypertrophy.
Topics: Breast; Bromocriptine; Child; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypertrophy; Mammaplasty; Mastectomy, Subcutaneous; Prolactin; Treatment Failure | 2001 |
Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas.
Topics: Adenoma; Adenoma, Acidophil; Adenoma, Basophil; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Human Growth Hormone; Humans; Hyperglycemia; Hyperprolactinemia; Hypertension; Infertility, Female; Male; Middle Aged; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Radiosurgery; Safety; Treatment Outcome | 2000 |
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.
Topics: Amisulpride; Animals; Antipsychotic Agents; Binding, Competitive; Bromocriptine; Dopamine Agonists; Hyperprolactinemia; In Vitro Techniques; Indoles; Male; Pituitary Gland; Prolactin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Synaptosomes; Yawning | 2002 |
Delivery after bromocriptine therapy.
Topics: Adenoma; Adult; Bromocriptine; Delivery, Obstetric; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic | 1977 |
Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension.
Topics: Bromocriptine; Dopamine; Humans; Hyperprolactinemia; Hypertension; Methyldopa; Prolactin | 1977 |
Subcutaneous mastectomy as ultimate treatment of galactorrhea.
Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Mastectomy; Pregnancy | 1979 |
Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
Topics: Adult; Amenorrhea; Antipsychotic Agents; Bromocriptine; Female; Humans; Hyperprolactinemia; Oligomenorrhea; Prolactin | 1992 |
Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Hyperprolactinemia; Octreotide; Pituitary Neoplasms | 1992 |
Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient.
Topics: Adult; Bromocriptine; Complement Hemolytic Activity Assay; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Female; Humans; Hyperprolactinemia; Killer Cells, Natural; Male; Middle Aged; Prolactin | 1992 |
Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine; Female; Humans; Hyperprolactinemia; Hypophysectomy; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Hormones, Anterior; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1992 |
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium | 1992 |
Analysis of clinical backgrounds and pathogenesis of luteal-phase defect.
Topics: Bromocriptine; Chorionic Gonadotropin; Clomiphene; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Hyperprolactinemia; Immunoradiometric Assay; Infertility, Female; Luteal Phase; Luteinizing Hormone; Menotropins; Ovarian Follicle; Pituitary Gland; Progesterone; Prolactin; Thyrotropin-Releasing Hormone | 1992 |
Outcome and long-term effects of pregnancy in women with hyperprolactinaemia.
Topics: Adenoma; Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Hyperprolactinemia; Ovulation Induction; Parity; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis | 1992 |
Hyperprolactinemia and lens opacities.
Topics: Adult; Bromocriptine; Cataract; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Sex Factors | 1992 |
Acute administration of bromocriptine abolishes the hyperprolactinemic response induced by submaximal exercise in man.
Topics: Administration, Oral; Adult; Blood Pressure; Bromocriptine; Exercise; Heart Rate; Humans; Hyperprolactinemia; Male; Time Factors | 1992 |
Vaginal bromocriptine--clinical and biochemical effects.
Topics: Administration, Intravaginal; Administration, Rectal; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Prolactin | 1992 |
[Experiences with bromocriptine treatment of female infertility due to hyperprolactinemia].
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1992 |
[Prolactin disorders in patients with habitual abortion].
Topics: Abortion, Habitual; Adult; Bromocriptine; Female; Histocompatibility; HLA Antigens; Humans; Hyperprolactinemia; Interleukin-2; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes; Pregnancy | 1992 |
[The immunomodulating and hepatotropic effect of correcting hyperprolactinemia and hypophyseal gonadotropic dysfunction in liver cirrhosis patients].
Topics: Adjuvants, Immunologic; Adult; Bromocriptine; Chorionic Gonadotropin; Clomiphene; Drug Therapy, Combination; Gonadotropins, Pituitary; Hepatitis B; Humans; Hyperprolactinemia; Immunity, Cellular; Liver; Liver Cirrhosis; Male; Middle Aged; Pituitary Diseases | 1992 |
Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion.
Topics: Acromegaly; Administration, Oral; Adult; Aged; Bromocriptine; Female; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin | 1992 |
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats | 1992 |
Observations with Bromocriptin tablet.
Topics: Adult; Anovulation; Bromocriptine; Clomiphene; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Infant, Newborn; Infertility, Female; Lactation; Menotropins; Postpartum Period; Pregnancy | 1992 |
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia.
Topics: Administration, Oral; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Time Factors | 1992 |
Prolactin enhancement of its own uptake at the choroid plexus.
Topics: Animals; Autoradiography; Biological Transport; Bromocriptine; Choroid Plexus; Electrophoresis, Polyacrylamide Gel; Feedback; Female; Haloperidol; Hyperprolactinemia; Prolactin; Rats; Rats, Inbred Strains; Receptors, Prolactin | 1992 |
Cabergoline in the long-term therapy of hyperprolactinemic disorders.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma | 1992 |
A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion.
Topics: Adult; Autoantibodies; Bromocriptine; Chromatography, Gel; Dopamine; Female; Humans; Hyperprolactinemia; Ovulation; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1992 |
Vaginal bromocriptine.
Topics: Absorption; Administration, Intravaginal; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstrual Cycle; Tablets | 1991 |
Pituitary prolactinoma associated with polycystic ovary--case report.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; Vision Disorders | 1991 |
[The effects of pregnancy on prolactin secretion in occulted hyperprolactinemia].
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Postpartum Period; Pregnancy; Pregnancy Complications; Prolactin | 1991 |
Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia.
Topics: Acute Disease; Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Psychoses, Substance-Induced; Schizophrenia, Paranoid; Thioridazine | 1991 |
Paradoxical prolactin response to growth hormone-releasing hormone in a patient with hyperprolactinemia and empty sella.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Growth Hormone-Releasing Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Prolactin; Prolactinoma | 1991 |
Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
Topics: Administration, Intravaginal; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lactation; Postpartum Period | 1991 |
Effects of hachimijiogan on dopamine, serotonin and vasoactive intestinal peptide in plasma and hypothalamus in sulpiride-induced hyperprolactinemic rats.
Topics: Animals; Bromocriptine; Dopamine; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Hyperprolactinemia; Hypothalamus; Rats; Rats, Inbred Strains; Serotonin; Sulpiride; Vasoactive Intestinal Peptide | 1991 |
A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin | 1991 |
Continuous bromocriptine treatment of empty sella syndrome aggravating pregnancy. A case report.
Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Hyperprolactinemia; Infant, Newborn; Male; Pregnancy; Pregnancy Complications | 1991 |
[Hypothalamic syndrome with dexamethasone-dependent hypertension and hyperprolactinemia].
Topics: Abortion, Habitual; Adult; Bromocriptine; Dexamethasone; Female; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypertension; Hypothalamic Diseases; Pregnancy; Syndrome | 1991 |
[The origin of hyperprolactinemia associated with infertility and its treatment with Bromocriptin-Richter tablets].
Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy | 1991 |
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Oligomenorrhea; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Tomography, X-Ray Computed | 1991 |
Role of prolactin on Leydig, Sertoli and germ cellular neutral lipids in bonnet monkeys, Macaca radiata.
Topics: Aging; Animals; Bromocriptine; Cholesterol; Glycerides; Hyperprolactinemia; Leydig Cells; Lipid Metabolism; Macaca radiata; Male; Prolactin; Sertoli Cells; Spermatozoa | 1991 |
The levels of pituitary-testicular axis hormones and SHBG in active acromegaly following bromocriptine treatment.
Topics: Acromegaly; Adult; Bromocriptine; Circadian Rhythm; Follicle Stimulating Hormone; Growth Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland; Saliva; Sex Hormone-Binding Globulin; Testis; Testosterone | 1991 |
[State of the breasts in patients with hyperprolactinemia-induced amenorrhea and the effect of the treatment with parlodel].
Topics: Adult; Amenorrhea; Breast; Bromocriptine; Female; Fibrocystic Breast Disease; Humans; Hyperplasia; Hyperprolactinemia | 1991 |
Hyperprolactinemia in multiple sclerosis.
Topics: Adult; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothalamus; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1991 |
Experience with bromocriptine for the treatment of female infertility due to hyperprolactinemia.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1991 |
Transient hyperprolactinemia in infertile women with luteal phase deficiency.
Topics: Adult; Bromocriptine; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Luteal Phase; Menstruation Disturbances; Pregnancy | 1991 |
Hyperprolactinemia and galactorrhea associated with mammary prostheses and unresponsive to bromocriptine. A case report.
Topics: Administration, Oral; Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Mammaplasty; Postoperative Complications; Prostheses and Implants; Reoperation | 1991 |
[Clinical course and outcome of pregnancy in hyperprolactinemia].
Topics: Abortion, Threatened; Adult; Bromocriptine; Female; Fetal Hypoxia; Humans; Hyperprolactinemia; Infertility, Female; Obstetric Labor Complications; Pre-Eclampsia; Pregnancy | 1991 |
Osteoporosis associated with neuroleptic treatment. A case report.
Topics: Adult; Amenorrhea; Antipsychotic Agents; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Osteoporosis | 1990 |
[Endocrine infertility in hyperprolactinemia].
Topics: Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female | 1991 |
Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia.
Topics: Adult; Arthritis, Psoriatic; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Psoriasis | 1991 |
Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dopaminergic drugs.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pergolide; Prolactin; Tomography, X-Ray Computed | 1991 |
[Macroprolactinemia in a child].
Topics: Adolescent; Bromocriptine; Chromatography, Gel; Dwarfism; Humans; Hyperprolactinemia; Male; Prolactin | 1990 |
Treatment of hyperprolactinemia in major depression.
Topics: Adult; Bromocriptine; Depressive Disorder; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
[A hormone assay as a therapeutic choice in male sterility].
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hyperprolactinemia; Hypogonadism; Infertility, Male; Luteinizing Hormone; Male; Menotropins; Prolactin; Sperm Count; Tamoxifen; Testosterone | 1990 |
Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism.
Topics: Adult; Aldosterone; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; Follicle Stimulating Hormone; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypothyroidism; Luteinizing Hormone; Monoiodotyrosine; Norepinephrine; Prolactin; Thyrotropin; Thyroxine | 1990 |
[Prolactin adenomas in Dakar].
Topics: Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prevalence; Prolactinoma; Radiography; Retrospective Studies; Sella Turcica; Senegal; Vision Disorders | 1990 |
[Polycystic ovary syndrome with excess of prolactin].
Topics: Adult; Bromocriptine; Clomiphene; Dehydroepiandrosterone; Dexamethasone; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Norethindrone; Polycystic Ovary Syndrome; Prolactin | 1990 |
Pituitary-adrenocortical and lymphocyte responses to bromocriptine-induced hypoprolactinemia, adrenocorticotropic hormone, and restraint in swine.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Bromocriptine; Growth Hormone; Hydrocortisone; Hyperprolactinemia; Interleukin-2; Lymphocyte Activation; Lymphocytes; Male; Pituitary-Adrenal System; Prolactin; Restraint, Physical; Swine; Swine Diseases | 1990 |
Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiography; Sella Turcica; Time Factors | 1990 |
Navy helicopter pilot with a juxtasellar mass: case report with aeromedical considerations.
Topics: Adult; Aerospace Medicine; Aircraft; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Hypothalamic Neoplasms; Magnetic Resonance Imaging; Male; Sella Turcica | 1990 |
[What is new in hyperprolactinemia?].
Topics: Abortion, Spontaneous; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1990 |
Serum prolactin levels during extended cocaine abstinence.
Topics: Bromocriptine; Cocaine; Hospitalization; Humans; Hyperprolactinemia; Male; Prolactin; Substance-Related Disorders; Therapeutic Community | 1990 |
New perspectives in medical management of hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Cabergoline; Delayed-Action Preparations; Empty Sella Syndrome; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1990 |
Normoprolactinaemia in spontaneously hypertensive rats: absence of a close relationship between plasma concentrations of prolactin and systolic blood pressure.
Topics: Animals; Bromocriptine; Disease Models, Animal; Female; Hyperprolactinemia; Hypertension; Immobilization; Male; Prolactin; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Serotonin; Testosterone | 1990 |
[Hyperprolactinemia syndrome in men].
Topics: Adult; Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Infertility, Male; Lisuride; Male; Middle Aged; Oligospermia; Prolactin; Syndrome | 1990 |
Bromocriptine treatment in patients with late onset acne and idiopathic hyperprolactinemia.
Topics: Acne Vulgaris; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia | 1988 |
Pituitary testing with and without bromocryptine in an aspermic man with elevated serum prolactin/FSH levels.
Topics: Adult; Blood Glucose; Bromocriptine; Clomiphene; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Infertility, Male; Insulin; Luteinizing Hormone; Male; Pituitary Function Tests; Pituitary Hormone-Releasing Hormones; Prolactin | 1989 |
Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function.
Topics: Adult; Biomarkers; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstrual Cycle; Ovary; Pregnancy; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1989 |
Morphea after bromocriptine therapy.
Topics: Biopsy; Bromocriptine; Drug Eruptions; Humans; Hyperprolactinemia; Male; Middle Aged; Scleroderma, Localized; Skin | 1989 |
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1989 |
[Effectiveness of lysenyl-forte treatment in acromegaly and hyperprolactinemia syndrome].
Topics: Acromegaly; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Syndrome | 1989 |
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
Topics: Adenoma; Amenorrhea; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pharmaceutical Vehicles; Pituitary Neoplasms | 1989 |
[Clinico-diagnostic indicators and late results of the treatment of infertility in hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactin; Time Factors | 1989 |
[Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Prolactin | 1989 |
Paedophilia and hyperprolactinaemia.
Topics: Adult; Bromocriptine; Erectile Dysfunction; Humans; Hyperprolactinemia; Libido; Male; Neurocognitive Disorders; Paraphilic Disorders; Pedophilia; Prolactin | 1989 |
Maturation events of epididymis in albino rats during puberal transition under hypo and hyperprolactinemia.
Topics: Animals; Bromocriptine; Epididymis; Hyperprolactinemia; Male; Prolactin; Rats; Rats, Inbred Strains; Sexual Maturation | 1989 |
[The characteristics of the hormonal interrelationships in a pregnancy stimulated with parlodel].
Topics: Bromocriptine; Drug Evaluation; Female; Hormones; Humans; Hyperprolactinemia; Infertility, Female; Labor, Obstetric; Postpartum Period; Pregnancy; Stimulation, Chemical | 1989 |
Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
Topics: Adult; Bromocriptine; Drugs, Chinese Herbal; Female; Humans; Hyperprolactinemia; Infertility, Female; Ovulation; Pregnancy; Prolactin | 1989 |
Effects of pregnancy, delivery and lactation in hyperprolactinemia with prolactin producing pituitary adenoma.
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Labor, Obstetric; Lactation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1989 |
Hyperprolactinemia and its management.
Topics: Adult; Bromocriptine; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Prolactinoma | 1989 |
The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilization.
Topics: Bromocriptine; Estradiol; Female; Fertilization in Vitro; Humans; Hyperprolactinemia; Oocytes; Pregnancy; Time Factors | 1989 |
Outcome of treatment with bromocriptine in patients with hyperprolactinaemia.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Middle Aged; Ovulation; Pituitary Neoplasms; Pregnancy | 1989 |
Bromocriptine inhibition of anesthesia-induced hyperprolactinemia: effect on serum and follicular fluid hormones, oocyte fertilization, and embryo cleavage rates during in vitro fertilization.
Topics: Adult; Anesthesia; Body Fluids; Bromocriptine; Cleavage Stage, Ovum; Female; Fertilization in Vitro; Gonadal Steroid Hormones; Hormones; Humans; Hyperprolactinemia; Osmolar Concentration; Ovarian Follicle; Prolactin | 1989 |
[Hyperprolactinemia. Reproductive consequences].
Topics: Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Lactation Disorders; Menstruation Disturbances | 1989 |
Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
Topics: Adolescent; Adult; Amenorrhea; Antipsychotic Agents; Bromocriptine; Erectile Dysfunction; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Luteinizing Hormone; Male; Middle Aged; Prolactin; Psychotic Disorders; Testosterone | 1986 |
Control of hyperprolactinemia with pergolide.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Prolactin; Psychotic Disorders | 1988 |
Multiple endocrine neoplasia--type I syndrome and hyperprolactinemia.
Topics: Adult; Bromocriptine; Calcium; Female; Humans; Hyperprolactinemia; Multiple Endocrine Neoplasia; Parathyroid Hormone; Pedigree | 1988 |
Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia.
Topics: Adult; Antipsychotic Agents; Bone and Bones; Bromocriptine; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hirsutism; Humans; Hyperprolactinemia; Osteoporosis; Thyroxine | 1988 |
Case-control cytogenetic study in offspring of mothers treated with bromocriptine during early pregnancy.
Topics: Bromocriptine; Child; Child, Preschool; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infant; Male; Maternal-Fetal Exchange; Pregnancy | 1989 |
Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Prolactin | 1989 |
Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lactation; Menstruation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Prolactinoma; Weaning | 1989 |
[Pathogenesis of uremic hypogonadism and its treatment with parlodel].
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypogonadism; Middle Aged; Uremia | 1985 |
[Pathogenesis and treatment of various forms of the climacteric syndrome].
Topics: Bromocriptine; Climacteric; Female; Humans; Hyperprolactinemia; Menopause; Middle Aged; Prolactin; Syndrome | 1986 |
[Parlodel treatment in the diagnosis of hyperprolactinemia].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Pituitary Neoplasms | 1986 |
[Retrospective analysis of infertile patients in a female reproductive endocrinologic clinic].
Topics: Adult; Bromocriptine; Clomiphene; Endometrial Hyperplasia; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Retrospective Studies | 1988 |
[Various treatment regimens in infertility using bromoergocryptine in women with hyperprolactinemia].
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy | 1988 |
The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Bromocriptine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hyperprolactinemia; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Prolactin; Reference Values | 1986 |
Increased water excretion in hyperprolactinemic rats.
Topics: Animals; Bromocriptine; Corticosterone; Diuresis; Female; Hyperprolactinemia; Male; Muscles; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Prolactin | 1986 |
Effects of physiological and abnormally elevated prolactin levels on the pituitary-testicular axis.
Topics: Animals; Bromocriptine; Cricetinae; Follicle Stimulating Hormone; Hyperprolactinemia; Male; Melatonin; Mesocricetus; Periodicity; Pituitary Gland; Prolactin; Receptors, Cell Surface; Receptors, LH; Receptors, Prolactin; Sexual Maturation; Testis; Testosterone | 1986 |
Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
Topics: Animals; Bromocriptine; Calcium; Cyclic AMP; Dihydroxyphenylalanine; Dopamine; Female; Haloperidol; Hyperprolactinemia; Hypophysectomy; Median Eminence; Potassium; Prolactin; Rats; Rats, Inbred Strains; Sodium | 1986 |
Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Metoclopramide; Oligomenorrhea; Prolactin; Thyrotropin-Releasing Hormone | 1986 |
Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia.
Topics: alpha-Methyltyrosine; Bromocriptine; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Infusions, Parenteral; Male; Methyltyrosines; Pituitary Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1986 |
[Effects of transient or occult hyperprolactinemia on luteal function].
Topics: Adult; Bromocriptine; Circadian Rhythm; Corpus Luteum; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Progesterone; Prolactin | 1986 |
Reduced number of natural killer cells in patients with pathological hyperprolactinemia.
Topics: Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Bromocriptine; Cytotoxicity, Immunologic; Female; Humans; Hyperprolactinemia; Killer Cells, Natural; Leukocyte Count; Prolactin | 1986 |
Rapid progression of a growth hormone producing tumour during dopamine agonist treatment.
Topics: Acromegaly; Adult; Bromocriptine; Growth Hormone; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1987 |
[Role of TRH or metoclopramide loading test in the diagnosis of so-called occult or latent hyperprolactinemia].
Topics: Adult; Bromocriptine; Circadian Rhythm; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Metoclopramide; Prolactin; Thyrotropin-Releasing Hormone | 1987 |
Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Levodopa; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin | 1987 |
Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
Topics: Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Menopause; Middle Aged; Prolactin | 1988 |
Galactorrhea in a young teenage girl.
Topics: Adolescent; Bromocriptine; Female; Galactorrhea; Humans; Hyperplasia; Hyperprolactinemia; Lactation Disorders; Pituitary Gland; Prolactin; Radiography | 1988 |
Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
Topics: Aging; Animals; Animals, Newborn; Bromocriptine; Dopamine; Estrus; Female; Hyperprolactinemia; Lactation; Median Eminence; Pituitary Gland; Pregnancy; Prolactin; Rats; Reference Values; Sexual Maturation; Thyrotropin-Releasing Hormone; Transcription, Genetic | 1988 |
Precocious puberty associated with hyperprolactinemia in a male patient.
Topics: Bromocriptine; Child; Follicle Stimulating Hormone; Growth Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Male; Puberty, Precocious; Thyroid Hormones | 1988 |
[The physiopathological aspects of the normoprolactinemic amenorrhea-galactorrhea syndrome].
Topics: Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Metoclopramide; Prolactin; Syndrome | 1987 |
Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.
Topics: Bone Diseases, Metabolic; Bromocriptine; Female; Humans; Hyperprolactinemia; Middle Aged; Spinal Diseases | 1988 |
Hyperprolactinemia and impotence.
Topics: Adolescent; Adult; Bromocriptine; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin | 1988 |
Pulsatile LHRH therapy for induction of ovulation in patients with hyperprolactinaemia and bromocriptine intolerance.
Topics: Adult; Anovulation; Bromocriptine; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Ovulation Induction | 1987 |
Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment.
Topics: Adult; Bromocriptine; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Hyperprolactinemia; Menstrual Cycle; Oocytes; Ovary | 1988 |
Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
Topics: Adenoma; Bromocriptine; Climacteric; Female; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactin | 1988 |
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1988 |
Validation of the role of bromocriptine in the primary treatment of prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1988 |
Long-acting injectable bromocriptine treatment for macroprolactinomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactin; Visual Acuity | 1988 |
[Uremic hypogonadism syndrome and the possibilities of its treatment].
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypogonadism; Kidney Failure, Chronic; Menstrual Cycle; Ovary; Renal Dialysis; Syndrome; Uremia | 1988 |
The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine.
Topics: Adult; Bromocriptine; Corpus Luteum; Female; Humans; Hyperprolactinemia; Infertility, Female; Luteal Phase; Progesterone; Prolactin | 1988 |
Effect of bromocriptine in hyperprolactinemia.
Topics: Affective Symptoms; Bromocriptine; Female; Humans; Hyperprolactinemia | 1988 |
Role of prolactin on neural and glial cellular enzymes involved in carbohydrate metabolism. I. Studies on immature male bonnet monkeys.
Topics: Animals; Brain; Bromocriptine; Carbohydrate Dehydrogenases; Hyperprolactinemia; Macaca; Macaca radiata; Male; Neuroglia; Neurons; Prolactin; Pyruvate Kinase | 1988 |
Long-term treatment of hyperprolactinaemia with bromocriptine: effect of drug withdrawal.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
13 trisomy born to a mother treated with bromocriptine: incidental or not?
Topics: Adult; Bromocriptine; Chromosomes, Human, Pair 13; Female; Galactorrhea; Humans; Hyperprolactinemia; Infant, Newborn; Male; Pregnancy; Trisomy | 1987 |
Decrease in serum prolactin during bromocriptine-induced pregnancy and subsequent restoration of reproductive function in some hyperprolactinemic women.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Prolactin | 1987 |
Effective management of a suprasellar extending prolactinoma during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Tomography, X-Ray Computed; Visual Fields | 1987 |
Hyperprolactinaemia in Zimbabwean women.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Pregnancy; Zimbabwe | 1987 |
Does treatment with bromocriptine influence the course of hyperprolactinaemia?
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Middle Aged; Prolactin; Retrospective Studies | 1987 |
Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
Topics: Bromocriptine; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin | 1986 |
Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin; Levodopa; Pituitary Neoplasms | 1986 |
Further acquisitions on gonadal function in bromocriptine treated hyperprolactinemic male patients.
Topics: Adult; Bromocriptine; Circadian Rhythm; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Hypogonadism; Luteinizing Hormone; Male; Testosterone | 1986 |
Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
Topics: Adult; Amenorrhea; Bromocriptine; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone | 1987 |
[Pregnancy and hyperprolactinemia. Review of therapeutic measures apropos of a series of 35 patients].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic | 1986 |
[Hyperprolactinemia and ovarian function].
Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Lisuride; Menstruation Disturbances; Ovary | 1986 |
Bromocriptine therapy and hyperprolactinemia.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Hyperprolactinemia; Male; Middle Aged | 1987 |
Hyperprolactinaemia--current dilemma.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1986 |
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1987 |
Primary amenorrhea associated with hyperprolactinemia: four cases with normal sellar architecture and absence of galactorrhea.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Pituitary Gland; Prolactin | 1987 |
Outcome of pregnancy in patients managed conservatively for hyperprolactinaemia.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Pregnancy; Pregnancy Complications; Prognosis; Prolactin | 1987 |
Long term treatment with oral single administration of bromocriptine in patients with hyperprolactinemia.
Topics: Administration, Oral; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged | 1987 |
[Therapeutic results in hyperprolactinemic sterility patients].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin | 1987 |
[Characteristics of the course of pregnancy and labor in women following parlodel treatment of sterility].
Topics: Adult; Bromocriptine; Chronic Disease; Drug Evaluation; Female; Humans; Hyperprolactinemia; Infertility, Female; Labor, Obstetric; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Time Factors | 1987 |
Medical management of hyperprolactinemia: a lower dose of bromocriptine may be effective.
Topics: Adult; Bromocriptine; Humans; Hyperprolactinemia; Patient Compliance; Prolactin; Prospective Studies | 1987 |
Experiences with the treatment of clinical hyperprolactinaemia.
Topics: Adult; Bromocriptine; Clomiphene; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Prolactin | 1987 |
Prolactin secretion and menstrual function after long-term bromocriptine treatment.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstruation; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Bromocriptine in pregnancy: safety aspects.
Topics: Abnormalities, Drug-Induced; Bromocriptine; Child Development; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Infant, Newborn; Infertility, Female; Pregnancy; Risk Factors | 1987 |
The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Dopamine; Drug Tolerance; Female; Humans; Hyperprolactinemia; Infusions, Intravenous; Injections, Intravenous; Male | 1987 |
Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
Topics: Animals; Bromocriptine; Drug Implants; Estradiol; Female; Fluphenazine; Hyperprolactinemia; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide | 1987 |
Report of the National Symposium on the Clinical Management of Prolactin-Related Reproductive Disorders.
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Luteal Phase; Ovarian Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields | 1986 |
[Experience with the treatment of hyperprolactinemic conditions].
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female | 1986 |
Osteoporosis in men with hyperprolactinemic hypogonadism.
Topics: Adenoma; Adult; Aged; Bone and Bones; Bromocriptine; Follow-Up Studies; Forearm; Humans; Hyperprolactinemia; Hypogonadism; Lumbar Vertebrae; Male; Middle Aged; Minerals; Osteoporosis; Pituitary Neoplasms; Radionuclide Imaging; Testosterone | 1986 |
Hyperprolactinemia associated with chronic renal failure in the rat.
Topics: Animals; Bromocriptine; Cells, Cultured; Creatinine; Dopamine; Hyperprolactinemia; Kidney Failure, Chronic; Male; Metoclopramide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Secretory Rate; Time Factors | 1986 |
Hyperprolactinemia and mammary prostheses. A report of eight cases.
Topics: Adult; Anovulation; Breast; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Postoperative Complications; Pregnancy; Prolactin; Prostheses and Implants; Siloxanes | 1986 |
[Prolactin and female sterility].
Topics: Adult; Bromocriptine; Clomiphene; Female; Humans; Hyperprolactinemia; Hypogonadism; Infertility, Female; Ovulation Induction | 1986 |
Sexual dysfunction secondary to cocaine abuse in two patients.
Topics: Adult; Bromocriptine; Cocaine; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Sexual Dysfunctions, Psychological; Substance-Related Disorders | 1986 |
Osmotic threshold for vasopressin release in hyperprolactinemic patients.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infusions, Parenteral; Male; Prolactin; Sodium Chloride; Vasopressins; Water-Electrolyte Balance | 1986 |
[Role of prolactin in disorders of water and salt metabolism in patients with hypertension].
Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Furosemide; Humans; Hyperprolactinemia; Hypertension; Male; Natriuresis; Potassium; Water-Electrolyte Imbalance | 1986 |
The endometrial biopsy as a guide to the treatment of the luteal phase defect associated with hyperprolactinemia.
Topics: Adult; Biopsy; Bromocriptine; Clomiphene; Endometrium; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstruation Disturbances; Pregnancy; Progesterone; Prolactin | 1986 |
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Cabergoline; Ergolines; Female; Growth Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Time Factors | 1986 |
The management of hyperprolactinaemia.
Topics: Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Tomography, X-Ray Computed | 1986 |
Dopamine agonists for reducing depression associated with hyperprolactinemia.
Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
Pregnancy, delivery and lactation in hyperprolactinaemic women.
Topics: Bromocriptine; Delivery, Obstetric; Female; Humans; Hyperprolactinemia; Infant, Newborn; Lactation; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Prolactin | 1986 |
[Evaluation of secondary ovulation induction using bromocriptine in normo- and hyperprolactinemia].
Topics: Adolescent; Adult; Anovulation; Bromocriptine; Female; Humans; Hyperprolactinemia; Ovulation Induction; Prolactin | 1986 |
Hyperprolactinemia in infertile Thai women, its incidence and treatment with bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Thailand | 1985 |
Hyperprolactinemia and its effect on female sterility.
Topics: Biopsy; Bromocriptine; Endometrium; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Ovulation; Ovulation Induction; Pregnancy; Prolactin | 1985 |
[Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Menstruation Disturbances; Oligomenorrhea; Pituitary Neoplasms; Pregnancy; Prolactin; Testosterone | 1985 |
Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
Topics: Adenoma; Adult; Bromocriptine; Female; Follicular Phase; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1985 |
Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.
Topics: Adolescent; Adult; Bone and Bones; Bromocriptine; Female; Forearm; Humans; Hyperprolactinemia; Middle Aged; Minerals; Time Factors | 1985 |
Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Middle Aged; Pituitary Neoplasms; Prolactin | 1985 |
Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
Topics: Aging; Animals; Bromocriptine; Cell Nucleus; Cytoplasmic Granules; Endoplasmic Reticulum; Female; Hyperprolactinemia; Lysosomes; Microscopy, Electron; Organ Size; Pituitary Gland, Anterior; Prolactin; Rats | 1986 |
[Hyperprolactinemia].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Hormones; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Bromocriptine--an update.
Topics: Acromegaly; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Kinetics; Lactation; Male; Nausea; Parkinson Disease; Pregnancy | 1986 |
[Hyperprolactinemia and prolactinomas. Results of surgical and drug therapy].
Topics: Adolescent; Adult; Aged; Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Paraneoplastic Endocrine Syndromes; Prolactin | 1985 |
Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Sex Factors; Thioridazine | 1985 |
[Hyperprolactinemic ovulation disorders].
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Ovary; Prolactin | 1985 |
Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1985 |
Dopamine agonists in hyperprolactinemia.
Topics: Bromocriptine; Ergolines; Humans; Hyperprolactinemia; Pergolide | 1985 |
Hyperprolactinemia and sexual function in men.
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Penile Erection; Pituitary Neoplasms; Prolactin; Psychotherapy; Sex | 1985 |
Management of borderline hyperprolactinemia.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstruation Disturbances; Prolactin | 1985 |
Which treatment for hyperprolactinemic females?
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Ovary; Pituitary Neoplasms; Risk | 1985 |
Medical treatment of hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Drug Resistance; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prognosis; Prolactin; Reference Values | 1985 |
[Why should benign mastopathies be treated medically?].
Topics: Biopsy; Breast; Breast Diseases; Bromocriptine; Diagnosis, Differential; Ethics, Medical; Female; Hormones; Humans; Hyperprolactinemia | 1985 |
[Hyperprolactinemia and pregnancy].
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1985 |
Treatment of galactorrhea-amenorrhea.
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Pituitary Neoplasms | 1985 |
[Current status of gynecologic hormone therapy. Prolactin-induced disorders].
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
Endometriosis and various pelvic lesions associated with hyperprolactinemia.
Topics: Adult; Bromocriptine; Dysmenorrhea; Endometriosis; Female; Humans; Hyperprolactinemia; Infant, Newborn; Leiomyoma; Male; Middle Aged; Pregnancy; Prolactin; Uterine Neoplasms | 1985 |
[Treatment of uremic hypogonadism with parlodel].
Topics: Adult; Bromocriptine; Erectile Dysfunction; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Menstruation Disturbances; Middle Aged; Uremia | 1985 |